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1. Summary 
Double-strand breaks are among the most deleterious DNA lesions, with a single unrepaired 
break capable of inducing apoptosis. This highly cytotoxic damage requires a fast and efficient 
cellular response. DSBs are repaired in two distinct repair pathways: homologous recombination 
or non-homologous end joining. Both of these repair systems ensure recognition of the damage 
site, activation of the cell-cycle checkpoint and repair of the lesion.  
A key player in the DSB repair is the conserved Mre11-Rad50-Nbs1 complex. The enzymatic 
core of this assembly – Mre11-Rad50 – is highly conserved and found in all domains of life. 
Eukaryote-specific Nbs1 (Xrs2 in S. cerevisiae) is a signalling subunit transmitting the damage 
event to the ATM kinase.  
Rad50 shares homology with the SMC protein family. Its dimer comprises two globular bipartite 
ATPase domains and two coiled-coil domains. The nuclease Mre11 also forms a dimer and 
associates with Rad50. This conserved catalytic head is believed to recognize DSB and form a 
DNA-binding interface. Moreover, the MR complex takes part in the initial processing of DNA 
ends and signals the lesion to the cell-cycle control machinery activated via Nbs1-ATM 
interaction. Nbs1 carries Mre11- and ATM-binding motifs and mediates damage recognition 
with checkpoint activation. The MRN complex is required not only for the repair of mitotic 
DSBs but also plays a role in meiotic recombination, telomere maintenance and adaptive 
immune system development. This multifaceted behaviour of the complex lies in its enzymatic 
activities, as well as DNA bridging and tethering function and activation of ATM-induced repair 
signalling.  
This work attempted to characterize molecular principles of DNA recognition by the catalytic 
part of the bacterial Rad50. To this end, the enzymatic core of T. maritima Rad50 together with 
an interaction motif of Mre11 was crystallized with AMPPNP and a dsDNA molecule. In the 
structure, DNA binding is asymmetrical and involves residues on both the globular head of the 
Rad50 and the root of the coiled-coil domain. Further studies were performed to biochemically 
characterize the protein-DNA complex and the identified binding sites. The atomic model 
yielded a number of structural features that were analyzed in vitro and in vivo. Finally, 
significance of these features together with the current understanding of the DNA binding by the 
MRN complex are discussed. 
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2. Introduction 
2.1. DNA damage and repair 
Stability of the genetic information is one of the most crucial features of the cellular metabolism. 
However, a number of intra- and extracellular factors are able to compromise the composition or 
structure of the DNA, inducing either chemical modifications or direct breakage in the sugar-
phosphate backbone. Resulting local DNA alterations may interfere with progression of 
transcription and replication and as a consequence pose a threat to DNA integrity. 
A vast number of DNA lesions and modifications together with their respective repair 
mechanisms have been reported so far (Figure 1). Minor modifications (e. g. alkylations) that do 
not distort base-pairing and overall topology of the DNA can be readily repaired through direct 
DNA damage reversal (DDR). In most cases, DDR relies on the activity of a single enzyme, 
capable of removing UV-induced modifications without backbone incisions or base excisions 
(Eker et al. 2009).  
More complex base modifications that cannot be repaired by DDR are often subjected to base-
excision repair (BER) machinery. This pathway relies on a cross-talk between several co-factors 
of distinct enzymatic activities that ensure base excision, strand incision and removal of the 
sugar moiety. The resulting gap is refilled by BER-associated polymerases followed by ligation 
(Robertson et al. 2009). Both DDR and BER act on local modifications that do not affect the 
overall structure of the DNA and hence do not impede DNA metabolism. Hence, these repair 
pathways prevent small-scale deletions and sequence alterations during replication and 
transcription. More complex modifications, including inter- and intrastrand crosslinks locally 
distorting DNA structure, are mostly repaired by nucleotide-excision repair (NER) machinery 
(Nouspikel 2009). Damages subjected to this repair pathway arise mostly as a result of both 
intracellular and environmental stress, such as reactive oxygene species (ROS), ultraviolet (UV) 
radiation and genotoxic agents. Similarly to BER, the NER system employs a number of 
enzymatic factors that ensure sensing of the distorted DNA, local duplex melting and removal of 
the lesion-containing single-stranded fragment together with its flanking sequences. The missing 
segment is then filled by polymerase I and the newly synthesized polynucleotide chain is ligated 
with the remaining part of the strand. NER can occur co-transcriptionally and is then considered 
a separate repair pathway called transcription-coupled repair (TCR). DNA damage can severely 
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affect transcription progression, being harmful to the cell at two distinct levels: as a source of 
mutations and as an inducer of an altered gene expression profile. Therefore, TCR ensures that 
the lesions not repaired prior to transcription can be efficiently removed before they interfere 
with DNA metabolism. TCR and NER share the same overall scheme of the repair pathway and 
repair machineries except from the distortion-sensing step. In case of TCR, transcribing RNA 
polymerase II acts itself as a sensor of the DNA distortion, whereas NER employs other 
specialized protein complexes to sense the damage (Tornaletti 2009). 
Another type of DNA modification are mismatches, occasionally introduced into the newly 
synthesized strand during replication. Mismatches consist of erroneous base pairing, instead of 
Watson-Crick A-T and G-C pairing. From structural point of view they do not interfere with 
DNA metabolism but may lead to sequence alterations. Mismatches are repaired in a mismatch 
repair (MMR) pathway; they are recognized by the replication proofreading machinery and 
removed together with an adjacent DNA fragment. Finally, the gap is refilled by polymerase III  
(Kunz, Saito, and Schar 2009).  
 
 
 
Figure 1. Overview of DNA repair pathways. DNA can be repaired by direct damage reversal, base 
excision repair, nucleotide excision repair, transcription-coupled repair and mismatch repair systems, 
depending on the nature of the lesion. Adapted from: (Nouspikel 2009).  
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This work focused on double-strand break repair (DSBR), a DNA repair system employed for 
damages involving breakage of the sugar-phosphate backbone on both DNA strands within a 
short-span distance. This type of damage is severely harmful and its detailed description is 
presented in the following paragraphs. 
 
2.2. Causes of double-strand breaks 
Double-strand breaks (DSBs) are considered one of the most deleterious DNA lesions and pose a 
severe threat to genomic stability, with a single unrepaired break being capable of inducing 
apoptosis. DSBs can arise spontaneously in a number of ways of both intra- and extracellular 
origin, but are also introduced in a programmed manner during certain cellular processes like 
meiosis or recombination of immunoglobulin genes. Both programmed and non-programmed 
DSBs depend on common repair pathways.  
2.2.1. Double-strand breaks of endogenous source 
The most prominent DSB source is replication. Many of physical and chemical DNA poisons 
discussed below do not introduce DSBs directly, but affect replication progression. This 
replicative stress leads to fork stalling and consequently to fork collapse, thereby exposing 
“naked” DNA ends (Costanzo et al. 2001; Kuzminov 2001). Another endogenous source of 
DSBs is products of cellular metabolism like reactive oxygen species. ROS are generated during 
cellular respiration and lipid peroxidation but can also arise as a result of ionizing radiation. A 
number of ROS-induced modifications of DNA has been reported, including protein-DNA 
adducts, base modifications, abasic sites, single-strand breaks (SSBs) and inter- and intrastrand 
crosslinks (Waris and Ahsan 2006). These lesions are repaired predominantly by BER and NER 
systems. However, if this repair fails, the damage imposes stress during replication and can elicit 
double-strand break response. 
2.2.2. Double-strand breaks of exogenous source 
Primary causes of DSBs of extracellular origin are ionizing radiation (IR), UV light and 
genotoxic agents. The most frequent DNA damage resulting from UV radiation are cyclobutane 
pyrimidine dimers (CPDs) and 6-4 photoproducts. These lesions contain covalent linkages 
between neighbouring thymines or cytosines (Goodsell 2001). UV-induced DNA modifications 
distort the structure of DNA and hence, are mostly repaired by the NER system. However, unless 
Introduction 
 
5 
 
repaired, they contribute to replicative stress, leading to fork stalling and collapse (Limoli et al. 
2002). 
 
Another environmental source of DSB is IR. The spectrum of damage caused by IR is very 
broad, including direct base and sugar moiety modifications. Moreover, IR generates ROS that in 
turn damage DNA (Mahaney, Meek, and Lees-Miller 2009). An example of IR-induced DSB is 
two single-strand breaks occurring on complementary strands and in close proximity to each 
other (Breen and Murphy 1995). Also, unrepaired SSB can interfere with replication progress, 
leading to fork stalling and collapse (Sutherland et al. 2000). IR potential of introducing 
modifications in DNA and triggering cell death is employed in some cancer treatment therapies 
(Ciccia and Elledge 2010). 
 
A vast number of genotoxic agents that introduce severe DNA damage including DSBs have also 
been reported. Many of them cause inter- and intrastrand crosslinks, thereby interfering with 
transcription and replication (Bosco et al. 2004). A very specific group of chemical agents that 
damage DNA includes topoisomerase poisons like camptothecin, etoposide and their derivatives. 
These agents inhibit activity of topoisomerases and eventually cause defects in DNA structure. 
Distortions of DNA may in turn affect DNA metabolism, leading again to replication fork 
collapse. Equally harmful are alkylating agents attacking nitrogen atoms in base moieties and 
contributing to strand crosslinks (Singer 1986). Many of the genotoxic agents, including 
topoisomerase poisons, have found use as anti-cancer drugs.  
2.2.3. Double-strand breaks in cell physiology 
Introduced in a programmed manner and tightly regulated DSBs are a feature of certain cellular 
events. Such DSBs arise during meiosis and are fundamental to crossing-over reaction, 
allowing for exchange of genetic information between homologous chromosomes. This process 
takes place in prophase I of the meiotic division in sexually reproducing organisms. Crucial to 
meiotic DSB generation is Spo11 topoisomerase II that introduces an endonucleolytic cleavage 
on both DNA strands. This event fires off meiotic recombination, including crossing-over and 
break repair by homologous recombination (Keeney 2008). 
 
Programmed DSBs are also fundamental to proper immunoglobulins (Ig) and T-cell receptors 
(Tcr) expression in B and T cells, respectively, and as such are prerequisite for the adaptive 
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immunity development in vertebrates. Genes coding Igs and Tcrs require a highly regulated 
processing that consists in excision, relocation and religation of distinct genetic segments. These 
genetic segments: variable (V), diversity (D) and joining (J) can be recombined in an endless 
number of configurations in a process called V(D)J recombination. V(D)J is a powerful tool for 
generating Igs and Tcrs recognizing a variety of antigens. The process requires a programmed 
formation of DSBs by RAG1/RAG2 (recombination-activating genes) nucleases (McBlane et al. 
1995). Subsequently, the DSB site is processed by the non-homologous end joining repair 
machinery (Ma et al. 2002). 
 
In yeast Saccharomyces cerevisiae, programmed DSBs are introduced during mating-type 
switch. Yeast haploid cells exhibit a simple sexual differentiation based on a single MAT locus 
denominated as type a or type α. During the mating-type switch, a sequence-specific HO 
endonuclease introduces a DSB at MAT locus, followed by resection of this locus and homology-
governed repair. Homologous sequence involved in the repair process is a silent copy of the 
opposite MAT allele (Coic, Richard, and Haber 2006). 
 
2.3. DSB repair  
Unrepaired DSBs are among the most deleterious DNA lesions. Therefore, cells have developed 
a fast and efficient repair system, employing DSBs sensors, repair complexes and a signalling 
machinery. The two main DSB repair pathways are homologous recombination (HR) and non-
homologous end joining (NHEJ). HR is a highly faithful pathway, in which a non-damaged 
homologous DNA segment (usually a sister chromatid) governs the repair of the lesion. NHEJ is 
more error-prone and involves a partial resection of the broken DNA ends followed by ligation. 
Since NHEJ is not accompanied by a large-scale polymerase gap filling, deletions and sequence 
alterations often arise in the religated DNA helix.  
2.3.1. Homologous recombination  
The process of homologous recombination starts with an extensive resection of the damage site 
in the 5’-3’ direction, resulting in a generation of single-stranded 3’ overhangs (Figure 2, panel 
A). Upon sensing the DNA damage, the Mre11-Rad50-Nbs1 (MRN) complex together with the 
Sae2 nuclease (S. cerevisiae; CtIP in human, Ctp1 in S. pombe) catalyzes removal of a short 
oligonucleotide from each 5’ end. This short-term end processing is followed by a long-term 
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resection performed by ExoI or alternatively Dna2/Sgs1 complex. Resulting 3’ overhang is 
recognized by a ssDNA-binding factor RPA (replication-protein A) (Gasior et al. 1998; Wolner 
et al. 2003), which is believed to play multiple roles in the initiation of HR. Firstly, RPA 
removes secondary structures on the overhang. It facilitates the following step of the repair 
reaction during which Rad51 associates with ssDNA (Sung et al. 2003), and regulates resection 
by stimulating activity of the Sgs1 helicase and the Dna2 nuclease (Cejka et al. 2010). Moreover, 
the RPA-ssDNA complex is a target for cell-cycle control kinases, eliciting a cycle arrest until 
the damage is repaired (Ball et al. 2007; Zou and Elledge 2003). In the course of HR, RPA is 
slowly displaced from the DNA and exchanged for one of the most crucial HR proteins Rad51 
(RecA in E.coli). Since the affinity of RPA towards ssDNA is higher compared to Rad51, other 
protein factors contribute to the efficient cross-talk between RPA and Rad51. These 
recombination mediators in yeast include Rad52 and a two Rad51 paralogues: Rad55 and Rad57. 
Their role is to facilitate Rad51-DNA nucleofilament formation by loading Rad51 onto the RPA-
coated ssDNA end, mechanistic stabilization of the filament and its protection from helicases 
(Liu et al. 2011; Shinohara and Ogawa 1998).  
Rad51 coats tightly ssDNA, forming an extended presynaptic filament. The synaptic phase of the 
repair corresponds to the invasion of the filament into the homologous DNA fragment and its 
annealing to the homologous sequence into a structure called a D-loop. Next, Rad51 dissociates 
from the DNA, exposing the single-stranded 3’ end for priming the DNA synthesis. From this 
point on, the downstream steps of the repair can follow several pathways (Figure 2, panels B, C 
and D). In the double-strand break repair model, the second end of the damaged DNA is engaged 
in the D-loop, forming a double Holiday-junction. Resolution of this Holiday structure can result 
in both crossover an non-crossover products (Orr-Weaver and Szostak 1983).  
Alternatively, the invading strand can be displaced from the D-loop and annealed to a 
complementary strand associated with the other end of the break. This synthesis-dependent 
strand-annealing (SDSA) repair occurs preferentially during mitosis and results in non-crossover 
products (Ferguson and Holloman 1996).  
The D-loop can also assemble into a replication fork, in which the homologous sequence serves 
as a template for a replication-dependent repair. This break-induced replication (BIR) is active 
on telomere ends where the second DNA end is missing (Davis and Symington 2004). 
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Figure 2. Homologous recombination pathway. After end resection followed by the Rad51-
nucleofilament formation and D-loop generation (panel A), the break is repaired in double-strand break 
repair pathway (panel B), synthesis-depended strand annealing (panel C) or break-induced repair pathway 
(panel D). Adapted from: (Krejci et al. 2012).  
 
Homologous recombination not only plays a role in the DSBR, but is also involved in the repair 
of other types of damage, including single-strand gaps and interstrand crosslinks. Hypomorphic 
mutations in genes involved in HR were recognized to be the cause of many cancer types (e. g. 
breast, prostate, colon and pancreas) and a cancer predisposition syndrome Fanconi anaemia 
(Halazonetis, Gorgoulis, and Bartek 2008).  
2.3.2. NHEJ  
Classical non-homologous end joining repair is governed by a conserved set of sensoring and 
enzymatic factors (Figure 3). The pathway starts with a DSB recognition by the Ku dimer 
(heterodimer of Ku70 and Ku80), one of the most abundant non-histone nuclear proteins. Ku 
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exhibits very high affinity to DNA and is therefore considered the sensor of the DNA damage. 
Ku associates with the DNA ends independently of other proteins, but is at the same time 
indispensable for the recruitment of all downstream NHEJ factors to the damage site (Walker, 
Corpina, and Goldberg 2001; Mari et al. 2006).  
Ku and catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) participate in forming 
the active holoenzyme of the DNA-dependent protein kinase (DNA-PK) (Gottlieb and Jackson 
1993). DNA-PK carries a number of phosphorylation and autophosphorylation sites (Chan et al. 
2002; Meek et al. 2007). Although the exact role of these sites has not been fully examined, 
some reports link the phosphorylation state of the DNA-PK to conformational changes of the 
complex, which would govern the dynamics of the NHEJ progression (Uematsu et al. 2007). 
DNA-PK is also responsible for tethering DNA ends at the damage site (DeFazio et al. 2002).  
A bridging component XLF (also named Cernussos) links the recognition Ku-DNA-PK complex 
with the enzymatic core of NHEJ machinery: the XRCC4-LigIV complex. XLF was shown to 
stimulate ligation activity of the XRCC4-LigIV complex, in particular on mismatched or 
incompatible ends (Tsai, Kim, and Chu 2007; Gu et al. 2007).  
Depending on the structure of the DNA ends, different downstream enzymatic factors are 
recruited to the damage site in order to ensure proper repair reaction. If DNA ends contain 
overhangs, the ligation reaction can only be performed after a short-term processing, leading to 
generation of blunt ends. Overhangs can be removed or serve as a template for a local 
replication. Removal of the overhangs depends on Artemis. This nuclease exhibits intrinsic 5’-3’ 
exonuclease activity and a DNA-PK-dependent endonuclease activity (Ma et al. 2002). 
Alternatively, blunting of the overhangs can be performed by filling in the missing segment by 
the terminal deoxynucleotidyl transferase (Tdt) (Mahajan et al. 1999), polymerase µ and 
polymerase λ (Capp et al. 2006; Mahajan et al. 2002). Processing of the DNA ends also include 
addition of 5’ phosphate groups by DNA-PK-XRCC4-dependent polynucleotide kinase (PNK) 
(Chappell et al. 2002).  
In the end, processed DNA is ligated by the XRCC4-LigIV complex. Since the complex can 
associate with the Ku-DNA-PK assembly before the ends are fully processed, it is not clear at the 
moment how the ligation reaction is retarded and elicited in a timely-manner.  
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Figure 3. Classical non-homologous end joining pathway. Ku dimer recognizes DNA break and 
attracts downstream NHEJ-associated repair factors to the damage site. Prior to ligation, DNA ends are 
processed by Artemis nuclease and polymerases µ, λ and PNK. Adapted from: (van Gent and van der 
Burg 2007). 
 
Microhomology-mediated end-joining  
Microhomology-mediated end-joining (MMEJ) is concerned an alternative pathway of NHEJ. 
MMEJ can be elicited as a backup repair mechanism when short fragments of homology are 
available in the proximity of the break (so-called microhomologies) (Verkaik et al. 2002; 
Boulton and Jackson 1996). This rather error-prone pathway is believed to be little efficient in 
joining blunt DNA ends, but was found to be employed during Ig heavy chain class switch 
recombination in B cells (Yan et al. 2007). Both classical and alternative NHEJ pathways are 
supporting break repair at V(D)J recombination sites.  
Hypomorphic or loss-of-function mutations in NHEJ subunits have been linked to several human 
genetic disorders, often accompanied by neurological defects, radiosensitivity, microcephaly and 
severe combined immunodeficiency (SCID) (Kerzendorfer and O'Driscoll 2009). 
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2.4. Repair pathway choice 
NHEJ is a predominant repair pathway in mammalian cells, whereas yeast cells seem to employ 
mostly HR (Shrivastav, De Haro, and Nickoloff 2008). Since HR requires sister chromatid, its 
progression is limited to late S phase and G2 phase of the cell cycle. So far, the reason for the 
discrepancy in the repair pathway choice between lower and higher eukaryotes is not entirely 
clear and several hypotheses are under consideration. One postulates that the yeast NHEJ is less 
accurate and therefore less frequently employed. A few protein factors key to NHEJ in 
mammalian cells (e. g. DNA-PKcs, BRCA1 and Artemis) are missing in the the yeast NHEJ 
protein machinery. At the same time, mammalian genomes being far larger and structurally more 
complex than the yeast ones, pose an intrinsic difficulty for the HR machinery to find and 
recognize a homologous sequence within the vicinity of the damage.  
Repair pathway choice is also regulated at the cellular level. HR is favoured in S/G2 phases and 
NHEJ is restricted mostly to the remaining phases of the cell cycle. In mammalian cells this 
balance is presumably accomplished by interplay of several regulatory factors, with 53BP1-RIF1 
and BRCA1-CtIP being the most crucial complexes. 53BP1-RIF1 interacts with chromatin at 
DSBs sites and promotes further association of the downstream NHEJ machinery during G1 
phase (Zimmermann et al. 2013; Escribano-Diaz et al. 2013). In late S phase and G2 phase, 
53BP1-RIF1 interaction with chromatin is inhibited by the BRCA1-CtIP complex. Therefore, the 
BRCA1-CtIP assembly promotes HR. Moreover, the pathway choice is also regulated by cyclin 
dependent kinases (CDKs). In particular, phosphorylation of the yeast Sae2 nuclease occurring in 
the late S phase or G2 phase, stimulates resection activity of this protein required for HR 
(Huertas et al. 2008; Limbo et al. 2007). The phosphorylation state of the Sae2 also regulates its 
association with the MRN complex and BRCA1, hence favouring HR (Chen et al. 2008). 
Certainly, the regulatory network of the repair choice is highly complex. Many details of this 
fine-tuned regulation remain to be elucidated, especially in the light of the recent studies 
reporting more factors contributing to the HR/NHEJ balance. 
 
2.5. Mre11-Rad50-Nbs1 complex: structural characterization 
Rad50 and Mre11 are evolutionarily conserved and found in all domains of life, forming a very 
ancient DNA repair machinery. The MRN complex is essential for DSB sensing and repair but it 
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is involved in tethering broken ends and bridging distal DNA fragments, enzymatic processing of 
DNA ends and signalling the damage event with cell-cycle control machinery via Nbs1.  
 
Rad50 gene was found among other alleles implicated in radiation sensitivity in yeast (Cox and 
Parry 1968). Many of these alleles were later found to be involved in meiosis (Game et al. 1980). 
Rad50 exhibits a typical structural maintenance of chromosome (SMC) protein structure, 
containing two globular domains at N- and C-termini with Walker A and Walker B nucleotide-
binding motifs, respectively (Aravind, Walker, and Koonin 1999) (Figure 4).  
 
 
 
 
Figure 4. Mre11-Rad50-Nbs1 structure. A: domain structure of the subunits of the MRN complex, B: 
current understanding of the subunit arrangement in the MRN complex. BS: binding site.  
 
A long and flexible (up to 60 nm) stretch of amino acids separating the two Walker domains 
forms a characteristic anti-parallel α-helical coiled-coil structure (van Noort et al. 2003; de Jager 
et al. 2001; de Jager et al. 2004). The coiled-coil folds back on itself, bringing the two globular 
domains together (Hopfner et al. 2000; Hopfner et al. 2001). In first atomic resolution structure 
of the archeal Rad50, these domains give shape to lobe I and lobe II (Figure 5) (Hopfner et al. 
2000). Upon ATP and Mg2+ binding, Rad50 forms a homodimer. Remarkably, the ATP-binding 
interface involves nucleotide-binding domains (NBDs) of the opposite Rad50 monomers. In this 
head-to-tail arrangement, lobes 1 and 2 of one Rad50 monomer contact lobes 2 and 1 belonging 
to the opposite Rad50 molecule, respectively, and  form two bipartite ATPase domains (Figure 
5).  
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Figure 5. Catalytic head of the P. furiosus Rad50 dimer. Lobes 1 (dark blue) and 2 (teal blue) from 
opposite monomers sandwich Mg2+ (in orange) and AMPPNP (in pink). (PDB entry: 1F2T). 
 
Essential for the ATP binding is the signature motif: a highly conserved sequence located in the 
vicinity of the Walker B motif. The signature motif is a sensor for γ-phosphate of the ATP 
molecule. Binding of the ATP changes relative position of lobe 2 towards lobe 1, promoting 
ATP sandwiching and tight dimer formation. Notably, mutations within the signature motif 
abolish Rad50 dimerization and MRN activity (Hopfner et al. 2000; Moncalian et al. 2004). Like 
all SMC proteins, Rad50 undergoes structural rearrangements upon ATP binding and hydrolysis. 
These rearrangements occur primarily at the ATPase domain and appear to be linked to the 
binding of other MRN assembly factors (Lammens et al. 2011; Lim et al. 2011; Mockel et al. 
2012).  
The apex opposite of the ATPase domain is known as a hook (or hinge) domain (Hopfner et al. 
2002; Hopfner and Tainer 2003), with a conserved CXXC motif coordinating Zn2+. The Zn-hook 
is involved in MRN intermolecular interactions during DNA bridging (Hopfner et al. 2002; de 
Jager et al. 2004) and mutations in this motif lead to the DSBR deficiency in yeast (Wiltzius et 
al. 2005). The long coiled-coil domain has been implicated in bridging distal DNA ends, as well 
as binding of the Mre11 (Hopfner et al. 2001; Lammens et al. 2011; Williams et al. 2011; Lim et 
al. 2011; Mockel et al. 2012). 
 
Mre11 (meiotic recombination gene 11) was first identified in a genetic screen for meiosis-
deficient yeast mutants (Ajimura, Leem, and Ogawa 1993). Its DNA-binding properties are 
attributed to the two C-terminal DNA-binding domains (D'Amours and Jackson 2002; Williams, 
Williams, and Tainer 2007), which, together with the nucleolytic activity of the protein, points 
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out the Mre11-Rad50 core to be responsible for the DNA recognition, DNA binding and 
processing of the damaged ends. In vitro, Mre11 is involved in hairpin opening and exhibits 
ssDNA endonuclease and dsDNA 3→`5` exonuclease activity dependent on Mn 2+ (Paull and 
Gellert 1998; Hopkins and Paull 2008). Structural and biochemical data revealed that the archeal 
Mre11 can bind different DNA substrates and provided evidence for the Mre11 3→`5` 
exonuclease activity (Usui et al. 1998; Hopfner et al. 2001; Williams et al. 2008). 
From early on, one of the most puzzling questions in the field of DSB repair was lack of the 
5`→3` exonuclease activity in Mre11, required for the DNA end resection prior to HR. It was 
therefore assumed that Mre11 activity is somehow reversed in vivo. However, recent studies 
show clearly that Mre11 is only one of many nucleases involved in DNA end processing and that 
5’-3’ resection is performed by other factors. A number of these nucleases has been identified 
and exhaustively investigated, including Sae2, Dna2 and Exo1. 
Mre11 forms a homodimer and associates with the Rad50 dimer, binding to its coiled-coils 
(Hopfner et al. 2002; Lammens et al. 2011) (Figure 4). First structural insight into the Mre11 
architecture showed a dimeric protein with two active sites coordinating in total four Mn2+. Each 
monomer is formed by two distinct domains: the N-terminal domain containing 
phosphodiesterase motifs that build up the active site and the C-terminally located capping 
domain in the vicinity of the active site, partially closing the substrate binding cleft (Figures 4 
and 6). Dimerization occurs along a conserved patch of hydrophobic residues located in the N-
terminal segment of each monomer. 
 
 
 
Figure 6. Structure of the P. furiosus Mre11. Mre11 dimerizes along conserved hydrophobic motifs. 
Each monomer coordinates two Mn2+ (in orange) in its active site (PDB entry: 1II7). 
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Archeal Mre11 was also crystallized with two different DNA substrates mimicking broken DNA 
end or branched DNA (Williams et al. 2008). These substrates were chosen to gain structural 
insight into two distinct MR complex features: tethering broken ends (synaptic feature) and 
recognition of the stalled replication fork. The overall architecture of both DNA-free and DNA-
bound pfMre11 is almost identical, without significant conformation change induced by DNA 
binding. Understanding of the DNA-bound Mre11 models poses some difficulties since more 
recent Mre11-Rad50 atomic structures clearly argue against the location of the DNA-binding 
interface on Mre11. In principle, the position occupied by the DNA molecule in the DNA-bound 
Mre11 structure is sterically secluded in the Mre11-Rad50 dimer (Lim et al. 2011; Mockel et al. 
2012) (Figure 7).  
 
 
Figure 7. Structures of prokaryotic Mre11-DNA and Mre11-Rad50 complexes. Left panel: DNA 
mimicking DSB (PDB entry: 3DSC), middle panel: DNA mimicking stalled replication fork (PDB entry: 
3DSD). DNA-bound Mre11 structures became difficult to interpret when confronted with the Mre11-
Rad50 model from T. maritima (right panel, PDB entry: 3THO). Rad50 dimer clearly closes the proposed 
DNA-binding pocket on Mre11. 
 
Recent studies shed light on the eukaryotic Mre11 structure (Park et al. 2011; Schiller et al. 
2012). Most notably, yeast Mre11 model with Nbs1 peptide revealed first insights into Nbs1 
binding by the Mre11 and the involvement of Mre11 structural features in the outbreak of ataxia-
telangiectasia-like disease (ATLD). S. pombe Mre11 forms a flexible dimer with asymmetrically 
bound Nbs1 stabilizing the dimer interface. Furthermore, despite sharing the overall 3D 
architecture with prokaryotic orthologues, eukaryotic structures possess a large loop insertion at 
one end of the dimer interface and an additional helix in the capping domain (Schiller et al. 
2012). Interestingly, some of the ATLD mutations map to this regions, suggesting its 
involvement in the DSB-induced signalling.  
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Less functional and structural information is available about Nbs1 (Xrs2 in S.cerevisiae) – the 
only MRN subunit to be found exclusively in eukaryotes. Xrs2 was first reported to belong to the 
recombinational genes involved in the DNA repair in S. cerevisiae (Suslova, Fedorova, and 
Zhelezniakova 1975). The human orthologue was found during a genetic analysis of the cells 
derived from patients suffering from the Nijmegen breakage syndrome (NBS) (Varon et al. 
1998). Back then, the protein had alternative names nibrin and p95; later Nbs1 annotation was 
accepted and this name is used in this work as well. 
In general, Nbs1 orthologues show a very poor sequence conservation, except from Mre11- and 
ATM-binding motifs. Nbs1 carries an N-terminal forkhead associated (FHA) and tandem 
BRCA1 C-terminus (BRCT) domains, both commonly known for binding phosphoproteins 
(Figures 4 and 8) (Xu et al. 2008; Lloyd et al. 2009; Williams et al. 2009). This N-terminal 
segment forms an extended fold conserved from yeast to human, which is highly phosphorylated 
at a number of residues. Phosphorylation state of Nbs1 regulates the recruitment of downstream 
DNA damage and checkpoint proteins. 
 
 
 
Figure 8. Structure of the N-terminal segment of Nbs1 from S. pombe. Nbs1 carries FHA and tandem 
BRCT domains clustered at the N-terminus of the protein. (PDB entry: 3HUE). 
 
The poorly structured C-terminal part of the Nbs1 carries conserved ATM- and Mre11-binding 
sites. Therefore, it was suggested that Nbs1 is the signalling subunit of the MRN complex. 
Indeed, Nbs1/Xrs2 plays a role in mediating the DSB recognition and repair with the cell-cycle 
checkpoint machinery (Falck, Coates, and Jackson 2005; You et al. 2005; Lloyd et al. 2009; 
Williams et al. 2009). Nbs1-ATM interaction is also crucial for the induction of apoptosis 
(Stracker et al. 2007). However, recent structural and biochemical studies showed that in S. 
pombe Nbs1 also interacts with Ctp1 and promotes nuclease activity of the MR complex, thereby 
being involved in DNA processing (Lee et al. 2003). Nbs1 also possesses a nuclear localization 
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signal (NLS), responsible for transportation of the MRN complex from the cytoplasm to the 
nucleus (Desai-Mehta, Cerosaletti, and Concannon 2001). These reports clearly show that Nbs1 
plays a multifunctional role in the context of the MRN complex.  
Considering extended architecture of the N-terminal part of Nbs1, indispensable for the 
recruitment of downstream DSBR factors, and the long and flexible C-terminus interacting with 
the MR complex and ATM kinase, a model of clustering of the primary and secondary DSBR 
proteins through the Nbs1 has been proposed (Williams et al. 2009). 
 
2.6. Mre11-Rad50-Nbs1 complex in cell physiology 
The MRN complex is a multifunctional machinery: it is involved in the DSB recognition and 
repair, nucleolytic processing of the DSB ends, DNA tethering at the damage site, as well as cell-
cycle checkpoint activation. As discussed below, MRN is crucial not only in the repair of mitotic 
DSBs, but also in the development of the adaptive immune system, damage signalling, repair of 
collapsed replication fork, telomere maintenance and repair of meiotic DSBs. The importance of 
the MRN complex is demonstrated by the fact that null mutations in any of the three subunits of 
the complex are lethal during embryogenesis in mice (Xiao and Weaver 1997; Luo et al. 1999; 
Zhu et al. 2001) whereas polymorphic mutations are linked to Nijmegen breakage syndrome and 
ataxia-telangiectasia-like disease, severe genomic human disorders. Many years of research have 
contributed to the better understanding of the multifaceted behaviour of the complex but some 
key questions still remain to be answered.  
2.6.1. HR in mitotic DSB  
Mre11-Rad50-Nbs1 complex was implicated in the repair of mitotic DSBs as the major sensor of 
the DNA damage. Its role in homologous recombination is important to several aspects of this 
repair pathway and so far has been best described in yeast. Firstly, the endonucleolytic and not 
the exonucleolytic activity of Mre11 is indispensable for the 5’ resection prior to HR in yeast 
(Williams et al. 2008). Mre11, together with the Sae2 nuclease, was shown to perform the short-
term resection on broken DNA ends, facilitating further processing by ExoI or the Sgs1-Dna2 
complex. Also, MRX enhances recruitment of ExoI and the Sgs1-Dna2 complex to the damage 
site and therefore stimulates long-term resection (Shim et al. 2010).  
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This model seems not to be entirely true in mammals, where endonuclease-deficient Mre11 is 
embryonically lethal in mice (Buis et al. 2008). The same strong phenotype is observed in 
endonuclease-deficient Mre11 in S. pombe. Also, S. pombe and mammalian orthologues of Sae2 
(Ctp1 and CtIP, respectively) show very poor sequence conservation and, in contrast to Sae2, do 
not exhibit nuclease activity in vitro. However, CtIP was shown to interact with Mre11, which 
would suggest the stimulatory effect of CtIP on Mre11 (Limbo et al. 2007; Sartori et al. 2007). 
Certainly, the protein landscape in HR is far more complex in mammals and therefore the details 
of the mammalian resection still remain to be elucidated.   
Beside its enzymatic activity, the MRN/X complex plays a scaffolding function. Due to the 
intermolecular interactions via Zn-hooks,  MRN/X complexes bound to distally located DNA 
molecules could perform bridging function important in preventing sister chromatid separation 
during repair (Hopfner et al. 2002; Borde and Cobb 2009). 
2.6.2. NHEJ 
From early on, role of the MRN complex in NHEJ/MMEJ was rather puzzling. Since Ku showed 
much higher affinity for DNA, the MRN complex was no longer a candidate for a damage 
sensor. However, studies reported that the MRN complex is indeed involved in NHEJ (Zhuang et 
al. 2009) and MMEJ (Xie, Kwok, and Scully 2009; Rahal et al. 2010). Mre11 knockdown 
reduces both NHEJ and MMEJ efficiency in mammalian cells. In S. cerevisiae, end-joining 
defects caused by Mre11 deletion are rescued by nuclease-deficient Mre11, which would suggest 
that the MRN complex plays rather a structural and not enzymatic role in NHEJ (Zhang and 
Paull 2005). Also, the MRN response in classical NHEJ does not seem induce ATM activation. 
Certainly, the exact nature of the MRN roles in NHEJ/MMEJ remains to be elucidated, together 
with the employment of the complex in yeast versus vertebrate NHEJ. 
2.6.3. Telomeres 
Structurally, telomeres represent one part of a double-strand break. Therefore, it was intriguing 
to find several factors involved in the DNA-damage response to be associated with telomeres. In 
S. cerevisiae, the MRX complex associates with telomeres in the late S-phase and is needed for 
the recruitment of the telomerase Cdc13-Stn1-Ten1 (CST) complex to the telomeres (Takata, 
Tanaka, and Matsuura 2005). Deletion or disruption of the individual MRX subunits results in 
telomere shortening and subsequent cell senescence (Kironmai and Muniyappa 1997; Boulton 
Introduction 
 
19 
 
and Jackson 1998). In the absence of the functional MRX, the CST complex loses its affinity to 
telomeres. At the moment it is not clear how the MRX affects the association of the CST with 
telomeres. One hypothesis postulates that the MRX complex and/or its associated co-factors (e. 
g. Sae2) process telomeric DNA and generate short 3’ overhangs recognizable by Cdc13. Cdc13 
is a ssDNA-binding protein, mediating association of the CST complex with telomeres. 
Alternative explanation suggests that the MRX forms a structural scaffold for the CST complex 
on the telomere.  
DSBR machinery is also involved in vertebrate telomere maintenance. MRN complex can be 
found on telomeres and associated with shelterin complex responsible for protecting “naked” 
DNA ends (Lombard and Guarente 2000; Zhu et al. 2000). At the same time, telomeres devoid 
of the protective shelterin cap cannot recruit telomerase. Consequently, the exposed uncapped 
telomere end leads to the ATM-induced checkpoint activation characteristic for DSB-induced 
signalling (Takai, Smogorzewska, and de Lange 2003; Karlseder et al. 1999). 
2.6.4. Meiosis 
Spo11-generated DSBs during meiosis are characterized by covalently attached topoisomerase to 
each of the 5’ ends of the break. These protein-DNA adducts need to be removed prior to further 
resection. Removal of the Spo11 together with a short oligonucleotide is catalyzed by 
Mre11/Sae2 and enhanced by ExoI (Neale, Pan, and Keeney 2005; Garcia et al. 2011). 
Remaining single-stranded 3’ overhangs are then subjected to downstream steps of the HR. 
However, repair of these breaks requires a set of specialized factors involved exclusively in the 
repair of meiotic DSBs.  
2.6.5. Signalling 
Every DNA damage event has to be rapidly signalled to the cell-cycle control machinery, so that 
the cell gains time for repair and recovery and does not retain potentially mutagenic DNA 
rearrangements. The MRN complex actively participates in signal transduction of the DNA 
damage to the major DSB kinase ATM. Together with the genotoxic stress kinases DNA-PKcs 
and ATR (ataxia-telangiectasia and Rad3-related), ATM belongs to the phosphatidylinositol 3-
kinase-related kinase family (PIKKs), mediating a number of various stress responses 
(Lempiainen and Halazonetis 2009). ATM resides mostly in the nucleoplasm in a form of an 
inactive dimer that dissociates into monomers upon activation. The very first hallmark of the 
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ATM activation is its autophosphorylation on serine 1981 (in human), followed by the 
autophosphorylation of other residues. All these modifications are required to retain ATM at the 
damage site (Bakkenist and Kastan 2003; Lee and Paull 2004; Dupre, Boyer-Chatenet, and 
Gautier 2006).  
The exact nature of the ATM activation is not clear. However, the MRN complex, together with 
other sensor proteins BP531 and BRCA1, is required for this activation. In particular, a direct 
interaction between specific motifs on the ATM kinase and Nbs1 was shown to be indispensable 
for the ATM-induced signalling (Falck, Coates, and Jackson 2005; Stracker et al. 2007; 
Difilippantonio et al. 2007). ATM is a very promiscuous kinase and once activated, it 
phosphorylates a number of substrates. Those related to DSB-repair pathway include e. g. H2AX 
histone, checkpoint kinases Chk1 and Chk2, mammalian recombination mediator BRCA1, 
transcription regulator p53, DNA-PKcs, Artemis and all subunits of the MRN complex. 
Phosphorylation of p53 signals the DNA damage event to transcriptome regulatory network, 
including activation of both cell cycle checkpoint factors and apoptotic proteins (Choi et al. 
2012; Sullivan et al. 2012). By activating the checkpoint, the cell is given time to repair the break 
and recover from the damage event. Continuous signalling from the lesion site that cannot be 
repaired, leads to a metabolic shutdown and programmed cell death. Both responses are 
considered the cellular defense against genomic instability. 
2.6.6. Mre11-Rad50 complex in prokaryotes 
Best described prokaryotic Mre11-Rad50 orthologues is the SbcCD complex from E. coli (SbcD 
for Mre11 and SbcC for Rad50). The complex was first cloned and sequenced in 1989 (Naom et 
al. 1989). Sequence analysis revealed that sbcD and sbcC were related to the bacteriophage T4 
genes gp46/gp47 and bacteriophage T5 genes gpD13/gpD12, which in turn share homology with 
the eukaryotic Mre11 and Rad50 proteins (Leach, Lloyd, and Coulson 1992). Later, it was also 
shown that the SbcCD complex is mechanistically similar to the eukaryotic Mre11-Rad50 
complex (Sharples and Leach 1995).  
Both sbcCD genes are transcribed from the same promoter. The SbcCD complex was first 
implicated in preventing replication of long palindromic DNA segments. Palindromes tend to 
form secondary structures and contribute to replication fork stalling and collapse, thereby posing 
a threat to genome stability. Studies showed that mutations in sbcCD enhance palindrome 
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propagation (Chalker, Leach, and Lloyd 1988; Gibson, Leach, and Lloyd 1992). It was later 
found that the RecABC complex involved in prokaryotic homologous recombination is required 
for viability in sbcCD+ genetic background and in the presence of palindromes. This finding 
suggested that the initial SbcCD action on palindromic DNA is a prerequisite to the subsequent 
recombinational processing.  
SbcCD proteins were recombinantly expressed and biochemically characterized (Connelly and 
Leach 1996; Connelly et al. 1997; Connelly, Kirkham, and Leach 1998; Connelly, de Leau, and 
Leach 1999). SbcCD co-purified together; however, during gel filtration the complex fell apart 
and the reversion of this could be achieved by addition of Mn2+. The complex exhibited ATP-
dependent 3’-5’ exonuclease activity on dsDNA and ATP-independent endonuclease activity on 
ssDNA. It could also cleave hairpins, leaving 3’-hydroxyl and 5’-phosphate ends. Enzymatic 
activities required Mn2+ and were independent of the DNA sequence. All these findings, together 
with the in vivo evidence of the SbcCD localization on the chromosomal sites containing 
palindromic sequences supported the role of the complex in inhibiting replication of potentially 
harmful DNA segments (Eykelenboom et al. 2008). The same report showed that the ends of the 
SbcCD-cleaved DNA were required to promote resection and HR. 
Despite high similarities in sequence and predicted secondary structure between prokaryotic and 
eukaryotic MR complexes, there are some key differences between these orthologues. Firstly, the 
eukaryotic complex is bigger and contains additionally Nbs1. Differences are also observed at 
the level of quaternary structure arrangement. As reported so far, the eukaryotic MR complex 
always forms heterotetramers and higher oligomeres of heterotetrameric complexes. In contrast, 
prokaryotic MR complexes are stable as heterodimers, with possibility of forming higher-order 
oligomeres (de Jager et al. 2004). The MRN complex plays a much more complex role in the 
cellular physiology compared to its prokaryotic orthologue. However, since the overall 
secondary structure prediction together with tertiary structure seem to be very similar for both 
prokaryotic and eukaryotic MR orthologues, many biochemical and structural characteristics of 
the prokaryotic MR complex have served a great help elucidating the roles of the complex in 
eukaryotic DNA metabolism. 
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2.7. Disease  
A number of deficiencies are linked to the mutations in the MRN complex, all sharing molecular 
and phenotypical similarities with the ataxia-telangiectasia (AT) disorder, in which ATM gene is 
mutated (ataxia-telangiectasia mutated). AT is a neurodegenerative disease, caused by a 
defective DNA damage signalling (Savitsky et al. 1995). On a molecular level, AT is linked to a 
partial or complete loss of the ATM kinase activity due to distinct mutations (Gilad et al. 1998; 
Becker-Catania et al. 2000), and is manifested in decreased Ig levels (Sanal et al. 1999), 
chromosomal aberrations, telomere shortening (Metcalfe et al. 1996) and sensitivity to the DNA 
damaging agents (Taylor et al. 1975; Gatti 2001). AT patients not only suffer from 
uncoordinated movements (ataxia) and have dilated blood vessels (telangiectasia), but also show 
radiosensitivity, immune dysfunction and predisposition to cancer.  
In 1999, the first patient with symptoms close to AT was reported (Stewart et al. 1999). 
However, no telangectasia and immunodeficiency were observed and the progression of the 
disease was slower compared to AT. The new disorder was called ataxia-telangiectasia-like 
disease (ATLD) and linked to a point mutation in the Mre11. Since then, a number of other 
Mre11 mutations have been reported (Delia et al. 2004; Fernet et al. 2005; Uchisaka et al. 2009), 
all causing ATLD.  
Similarly, mutations in Nbs1 cause Nijmegen breakage syndrome (NBS) (Carney et al. 1998; 
Varon et al. 1998; Maser, Zinkel, and Petrini 2001), yet another disorder related to AT. Again, 
no telangiectasia was observed and in contrast to both AT and ATLD, NBS patients do not 
exhibit neurodegeneration. A characteristic symptom of NBS, uncommon for AT and ATLD, is 
microcephaly.  
So far, only one Rad50 mutation associated with a human disease has been described, with 
clinical characteristics similar to the NBS. The new disorder was annotated NBS- like disease 
(NBSLD) (Waltes et al. 2009). 
Subtle differences between disorders caused by the hypomorphic mutations in the MRN subunits 
clearly point out their related but also specialized function in the DNA damage response. In 
particular, the divergent effect on the development of the nervous system for AT, ATLD and 
NBS is so far not well understood. Details underlying the molecular and functional 
characteristics of the MRN subunits will certainly contribute to better understanding of the 
MRN-related disorders.  
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2.8. Mre11-Rad50 complex from Thermotoga maritima and other prokaryotes 
Recent studies have greatly advanced our understanding of the structural features in the 
prokaryotic Mre11-Rad50 complex. I particular, ATP-induced conformational changes within 
the complex have been mechanistically and functionally described (Lammens et al. 2011; Lim et 
al. 2011; Williams et al. 2011; Mockel et al. 2012). These studies shed light on the ATP-driven 
cross-talk between Rad50 and Mre11, giving a detailed insight into how ATP binding and 
hydrolysis influences the function of the complex (Moncalian et al. 2004; Bhaskara et al. 2007).  
Notably, it turned out that in the absence of ATP or its analogs, the Mre11-Rad50 complex from 
Thermotoga maritima, encompassing full-length Mre11 and the catalytic head of the Rad50 with 
the adjacent coiled-coil domains exhibits an elongated shape (Figure 9). The two monomers of 
the Rad50 are far apart, with the coiled-coils pointing out towards almost opposite directions 
(120°). Mre11 and Rad50 interact at two conserved interfaces, one formed between the Mre11 
capping domain and the Rad50 lobe 1 and the other involving a short helix-loop-helix motif of 
Mre11 and a hydrophobic patch in the Rad50 coiled-coils.  
Further SAXS and cross-linking studies showed that upon ATPS the structure becomes more 
compact due to ATPS-induced dimerization of the Rad50. At the same time, AMPPNP-driven 
engagement of the Rad50 globular domains was shown in structure of the Rad50 catalytic core 
with the helix-loop-helix motif of Mre11 (Lammens et al. 2011; Williams et al. 2011) (Figure 9).  
 
 
Figure 9. Mre11-Rad50 complexes from T. maritima. Left panel: in the absence of ATP analogs, the 
complex has an elongated shape with Rad50 monomers located far apart from each other (PDB entry: 
3QG5). Right panel: upon ATP binding, Rad50 dimerizes (PDB entry: 3QF7). 
 
Further atomic models of the archeal and bacterial full-length Mre11 co-crystallized with the 
catalytic core of the Rad50 in ATP/ADP bound state provided more details about the ATP-
induced conformational changes (Lim et al. 2011; Mockel et al. 2012). ATP-induced Rad50 
dimerization leads to changes at the Mre11 dimer interface, rendering the dimer more compact 
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and suggesting that the ATP binding and subsequent hydrolysis might be transmitted to the 
signalling component of the complex Nbs1 via Mre11. Interestingly, the relative Rad50-Mre11 
arrangement clearly obstructs the active site of Mre11 and contradicts previous results showing 
archeal Mre11 bound to DNA (Williams et al. 2008) (Figure 7). It remains to be elucidated how 
the entire complex coordinates DNA binding and how this binding, together with the ATP 
hydrolysis, contributes to the activation of the cell cycle control machinery. 
Considering structural and to a degree functional conservation between prokaryotic and 
eukaryotic Mre11/Rad50 orthologues, as well as the number of already reported prokaryotic 
crystal structures, the Rad50-Mre11 complex from Thermotoga maritma is a good starting point 
for structural investigations of the complex-DNA assembly. Having the structure in hand, 
biochemical and functional studies could be performed, including structure-based in vivo 
approach.  
 
2.9. Aims of the project 
Certainly, the MRN/MRX complex plays a pivotal role in various aspects of the DSB repair. Not 
only does it serve as a molecular sensor of the damage, but also actively participates in the repair 
process, exhibiting enzymatic activities. Furthermore, the complex forms a structural scaffold 
required for the recruitment and assembly of the downstream repair and signalling factors, 
thereby being a key component of the repair machinery. The importance of the Nbs1-regulated 
damage signalling manifested in severe phenotypes of AT- and NBS-related disorders further 
confirms the crucial role of the complex. Lastly, the broad spectrum of cellular events employing 
the MRN/MRX complex: telomere maintenance, meiotic recombination, immune system 
development to mention a few, gives this complex a particular importance in cell physiology.  
Although many years of extensive research have greatly contributed to dissecting the role and 
activity mechanism of the MRN complex, a number of fundamental questions is still a matter of 
debate. Certainly, the divergence in the requirement of the Mre11 nuclease activity in distinct 
MRN-dependent cellular events is still unclear. Furthermore, details of the subtle cross-talk 
between structural and enzymatic features of the complex and Nbs1-dependent ATM signalling 
require in-depth studies. Finally, the mechanism of DNA recognition and the regulation of the 
interplay between DNA binding and downstream repair and signalling events remain to be 
elucidated.  
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The aims of this thesis were to determine how the complex senses and binds DNA. To this end, 
the enzymatic core of the Rad50 from T. maritima comprising the nucleotide-binding domain 
(tmRad50NDB) together with a short interaction helix-loop-helix peptide of Mre11 (tmMre11HLH) 
was crystallized in a dimeric form with AMPPNP and a short dsDNA molecule. Moreover, 
significance of structural features of this model was analyzed in vitro in DNA-binding assays. 
Further attempts were undertaken to functionally characterize the importance of structure-based 
features of Rad50 in the DNA damage response, repair and telomere maintenance in vivo in S. 
cerevisiae and in ATM signalling in vitro in Xenopus laevis egg extract system with the 
recombinant hMRN complex.  
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3. Materials and methods 
3.1. Materials 
Chemicals used in this work were purchased from Sigma-Aldrich (Deisenhofen), Carl Roth 
(Karlsruhe) or Merck (Darmstadt). Enzymes used for molecular biology methods were obtained 
from Fermentas (St.Leon-Rot) or New England Biolabs (Frankfurt).  
Desalted oligonucleotides for molecular cloning were purchased from Metabion International 
AG (Martinsried), HPLC purified oligonucleotides for in vitro activity assays were obtained 
from Biomers.net (Ulm) and Thermo Fisher Scientific (Ulm). RP-HPLC and PAGE-purified 
oligonucleotides for crystallization were purchased from Biomers.net (Ulm) and Thermo Fisher 
Scientific (Ulm), respectively. 
Chromatographic media and columns were purchased from GE Healthcare (Munich). For 
crystallization experiments commercial screens and tools from Hampton Research (Laguna 
Niguel, USA), NeXtal (QIAGEN, Hilden) and Jena Bioscienes (Jena) were used.  
 
Oligonucleotides 
Table 1 lists oligonucleotides used for molecular cloning and mutagenesis relevant to this work. 
 
Table 1. Oligonucleotides used for molecular cloning and mutagenesis.  
oligonucleotide 5’-3’ sequence purpose 
hM11_Sma_F TTTCCCGGGATGAGTACTGCAGATG Fw primer, human Mre11 FL 
hM11_Kpn_R TTTGGTACCTCATCTTCTATTTCTTCTTAAAGAACTAGTG Rv primer, human Mre11 FL 
hR50_BamH_F TTTGGATCCATGTCCCGGATCGAAAAG Fw primer, human Rad50 FL 
hR50His_Xba_R TTTTCTAGATTAGTGGTGATGGTGATGGTGC Rv primer, human Rad50  
FL, 6xHis at C-terminus 
hR50_Xba_R TTTTCTAGATTAATGAACATTGAATCCCAGGGAGC Rv primer, human Rad50 FL 
hN_Sal_F TTTGTCGACATGTGGAAACTGCTGCC Fw primer, human Nbs1 FL 
hNHis_Not_R TTTGCGGCCGCTTAGTGGTGATGGTGATGGTGTCTTCTCCTTTTTAAATAA Rv primer, human Nbs1 FL,  
6xHis at C-terminus 
hN_Not_R TTTGCGGCCGCTTATCTTCTCCTTTTTAAATAAG Rv primer, human Nbs1 FL 
tmR50_R2Q_For CTTTAAGAAGGAGATATACATATGCAGCCTGAACGCCTCACCGTTAG  R2Q mutation in tmRad50 
tmR50_R2Q_Rev CTAACGGTGAGGCGTTCAGGCTGCATATGTATATCTCCTTCTTAAAG R2Q mutation in tmRad50 
tmR50_R5Q_For GAGATATACATATGCGCCCTGAACAATCACCGTTAGAAACTTTCTCG R5Q mutation in tmRad50 
tmR50_R5Q_Rev CGAGAAAGTTTCTAACGGTGAGTTGTTCAGGGCGCATATGTATATCTC R5Q mutation in tmRad50 
tmR50_R9E_For CCTGAACGCCTCACCGTTGAAAACTTTCTCGGACTGAAAAACG R9E mutation in tmRad50 
tmR50_R9E_Rev CGTTTTTCAGTCCGAGAAAGTTTTCAACGGTGAGGCGTTCAGG R9E mutation in tmRad50 
tmR50_N10D_For CTGAACGCCTCACCGTTAGAGACTTTCTCGGACTGAAAAACGTC N10D mutation in tmRad50 
tmR50_N10D_Rev GACGTTTTTCAGTCCGAGAAAGTCTCTAACGGTGAGGCGTTCAG N10D mutation in tmRad50 
tmR50_R94E_For GAGAGATAAATGCCCTGCAGGAAAAACACAACGCGAAGCTCTC R94E mutation in tmRad50 
tmR50_R94E_Rev GAGAGCTTCGCGTTGTGTTTTTCCTGCAGGGCATTTATCTCTC R94E mutation in tmRad50 
tmR50_K95E_For GAGATAAATGCCCTGCAGAGAGAACACAACGCGAAGCTCTC K95E mutation in tmRad50 
tmR50_K95E_Rev GAGAGCTTCGCGTTGTGTTCTCTCTGCAGGGCATTTATCTC K95E mutation in tmRad50 
tmR50_K99E_For CAGAGAAAACACAACGCGGAGCTCTCCGAGATACTGGAAAAC K99E mutation in tmRad50 
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tmR50_K99E_Rev GTTTTCCAGTATCTCGGAGAGCTCCGCGTTGTGTTTTCTCTG K99E mutation in tmRad50 
tmR50_K108E_For GAGATACTGGAAAACGGAGAGAAAGCGGCCATAGCTGCAAAAC K108E mutation in tmRad50 
tmR50_K108E_Rev GTTTTGCAGCTATGGCCGCTTTCTCTCCGTTTTCCAGTATCTC K108E mutation in tmRad50 
tmR50_K109E_For GAGATACTGGAAAACGGAAAGGAAGCGGCCATAGCTGCAAAAC K109E mutation in tmRad50 
tmR50_K109E_Rev GTTTTGCAGCTATGGCCGCTTCCTTTCCGTTTTCCAGTATCTC K109E mutation in tmRad50 
tmR50_K115E_For GAAAGAAAGCGGCCATAGCTGCAGAACCTACCAGTGTTAAGC K115E mutation in tmRad50 
tmR50_K115E_Rev GCTTAACACTGGTAGGTTCTGCAGCTATGGCCGCTTTCTTTC K115E mutation in tmRad50 
tmR50_K175E_For GAAACACTCGAAAAGCTGGAAGAACTCCTCAAAGAGAAAATGAAAAAGCTG K175E mutation in tmRad50 
tmR50_K175E_Rev CAGCTTTTTCATTTTCTCTTTGAGGAGTTCTTCCAGCTTTTCGAGTGTTTC K175E mutation in tmRad50 
tmR50_K182E_For GAAAAACTCCTCAAAGAGAAAATGGAAAAGCTGGAGAACGAGATATCC K182E mutation in tmRad50 
tmR50_K182E_Rev GGATATCTCGTTCTCCAGCTTTTCCATTTTCTCTTTGAGGAGTTTTTC K182E mutation in tmRad50 
tmR50_R765E_For GGTATCGAAAGACCAGCGGAGGGACTTTCCGGTGG R765E mutation in tmRad50 
tmR50_R765E_Rev CCACCGGAAAGTCCCTCCGCTGGTCTTTCGATACC R765E mutation in tmRad50 
tmR50_S768R_For GACCAGCGAGGGGACTTCGCGGTGGGGAAAGAGCTC S768R mutation in tmRad50 
tmR50_S768R_Rev GAGCTCTTTCCCCACCGCGAAGTCCCCTCGCTGGTC S768R mutation in tmRad50 
tmR50_E798Q_For GGACGCGTTCTTCATCGATCAAGGGTTTTCCAGTCTCGACACG E798Q mutation in tmRad50 
tmR50_E798Q_Rev CGTGTCGAGACTGGAAAACCCTTGATCGATGAAGAACGCGTCC E798Q mutation in tmRad50 
scR50_K103E_For CAGAAATATTCAGTTGCTAATGGAAAAGACTACTACTACATTTAAGAC K103E mutation in scRad50 
scR50_K103E_Rev GTCTTAAATGTAGTAGTAGTCTTTTCCATTAGCAACTGAATATTTCTG K103E mutation in scRad50 
scR50_K104E_For CAGAAATATTCAGTTGCTAATGAAAGAGACTACTACTACATTTAAGAC K104E mutation in scRad50 
scR50_K104E_Rev GTCTTAAATGTAGTAGTAGTCTCTTTCATTAGCAACTGAATATTTCTG K104E mutation in scRad50 
scR50_Q115E_For CATTTAAGACTTTAGAAGGCGAGTTGGTCGCTATAAATAATAGTGGTG Q115E mutation in scRad50 
scR50_Q115E_Rev CACCACTATTATTTATAGCGACCAACTCGCCTTCTAAAGTCTTAAATG Q115E mutation in scRad50 
scR50_R131E_For GACCGCAGTACTTTGTCCACCGAGTCTCTGGAATTAGACGCAC R131E mutation in scRad50 
scR50_R131E_Rev GTGCGTCTAATTCCAGAGACTCGGTGGACAAAGTACTGCGGTC R131E mutation in scRad50 
scR50_N190E_For GAAATTTACAAAGGCTCTAGACGAGTTAAAATCCATAAAGAAAGACATGTCCG N190E mutation in scRad50 
scR50_N190E_Rev CGGACATGTCTTTCTTTATGGATTTTAACTCGTCTAGAGCCTTTGTAAATTTC N190E mutation in scRad50 
scR50_R1201E_For GCAGGATGTTGAATTGGATATGGAGGGACGATGTTCCGCGG R1201E mutation in scRad50 
scR50_R1201E_Rev CCGCGGAACATCGTCCCTCCATATCCAATTCAACATCCTGC R1201E mutation in scRad50 
scR50_S1205R_For GAATTGGATATGAGAGGACGATGTCGCGCGGGTCAAAAAGTTCTTGCATC S1205R mutation in scRad50 
scR50_S1205R_Rev GATGCAAGAACTTTTTGACCCGCGCGACATCGTCCTCTCATATCCAATTC S1205R mutation in scRad50 
scR50_E1235Q_For GTGGCGTAATTGCACTAGACCAACCTACCACCAATTTAGATGAAG E1235Q mutation in scRad50 
scR50_E1235Q_For CTTCATCTAAATTGGTGGTAGGTTGGTCTAGTGCAATTACGCCAC E1235Q mutation in scRad50 
 
Oligonucleotides used for preparing short dsDNA to crystallize with tmRad50NBD-Mre11HLH are 
listed in Table 2. 
 
Table 2. Oligonucleotides used in the preparation of the DNA for crystallization experiments. 
oligonucleotide 5’-3’ sequence purpose 
Palin15_For GGTCGGTGACCGACC Fw primer, 15 bp palindromic DNA 
Palin15_Rev GGTCGGTCACCGACC Rv primer, 15 bp palindromic DNA 
13mer_for GGCGAGCCGTGGC Fw primer, 13 bp DNA 
13mer_rev GCCACGGCTCGCC Rv primer, 13 bp DNA 
15mer_for GCTGCGAGCCGTGGC Fw primer, 15 bp DNA 
15mer_rev GCCACGGCTCGCAGC Rv primer, 15 bp DNA 
17mer_for GCTGCGAGCCGTGGCCG Fw primer, 17 bp DNA 
17mer_rev CGGCCACGGCTCGCAGC Rv primer, 17 bp DNA 
19mer_for GCTGCGAGCCGTGGCCGTG Fw primer, 19 bp DNA 
19mer_rev CACGGCCACGGCTCGCAGC Rv primer, 19 bp DNA 
21mer_for ATAGGGCTATAAAAGGGGGTG Fw primer, 21 bp DNA 
21mer_rev CACCCCCTTTTATAGCCCTAT Rv primer, 21 bp DNA 
15mer[TT]_for TTGGCGAGCCGTGGC Fw primer, 15 bp DNA with 1 nt overhang 
16mer_rev TGCCACGGCTGCCAA Rv primer, 15 bp DNA with 1 nt overhang 
16merBr_rev UBrGCCACGGCTGCCAA Rv primer, 15 bp DNA with 1 nt overhang  
of bromouracil 
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Oligonucleotides used for preparing fluorescently labelled dsDNA for DNA binding assays with 
the recombinant tmRad50NBD-Mre11HLH are listed in Table 3. 
 
Table 3. Oligonucleotides used in the preparation of the DNA for the in vitro activity assays. 
oligonucleotide 5’-3’ sequence purpose label/ modification 
ss30_F CCGGAAAGCATCTAGCATCCTGTCAGCTGC Fw primer, 30 bp DNA 6-FAM at 5’ 
ss30_R GCAGCTGACAGGATGCTAGATGCTTTCCGG Rv primer, 30 bp DNA  
ss60_F GCTAATGCCGCGTGCCTTGTCTCACCTTCGATTTAGCATGGTATC
AGCAGAGCAAGCCTC 
Fw primer, 60 bp DNA 6-FAM at 5’ 
ss60_R GAGGCTTGCTCTGCTGATACCATGCTAAATCGAAGGTGAGACAA
GGCACGCGGCATTAC 
Rv primer, 60 bp DNA  
ss60_2_5’P CGAAGGTGAGACAAGGCACGCGGCATTAGC Rv primer, 60 bp nicked DNA phosphate group 
at 5’ 
ss60_1 GAGGCTTGCTCTGCTGATACCATGCTAAAT Rv primer, 60 bp nicked DNA  
 
Blunt-ended 200 bp DNA used for eliciting DNA damage response in Xenopus laevis egg 
extracts was prepared in a PCR with pBluescript II SK+ as DNA template and following 
primers: 
pBlue_For:             5’- GGGGGATCCACTAGTTCT-3’   (forward primer) 
pBlue200_Rev:      5’- TTTCACTCATTAGGCACCCC-3’   (reverse primer) 
 
Constructs 
Constructs of the human MRN complex and its subunits are listed in Table 4. All these 
constructs contain full-length wild-type ORFs.  
 
Table 4. pFBDM-based constructs of the human MRN complex and its subcomplexes. 
 
construct ORF tag restriction sites 
pFBDM:hMre11_hRad506His/C_hNbs1 hMre11  
hRad50  
hNbs1  
- 
6xHis at C-terminus 
- 
SmaI/KpnI 
BamHI/XbaI 
SalI/NotI 
pFBDM:hMre11 hMre11 - SmaI/KpnI 
pFBDM:hRad50 hRad50 - BamHI/XbaI 
pFBDM:hNbs16His/C hNbs1 6xHis at C-terminus SalI/NotI 
pFBDM:hMre11_hRad50 hMre11  
hRad50 
- 
- 
SmaI/KpnI 
BamHI/XbaI 
pFBDM:hMre11_hRad506His/C hMre11  
hRad50 
- 
- 
SmaI/KpnI 
BamHI/XbaI 
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Construct pET29b:tmRad50NBD_Mre11HLH containing segments of the wild-type Rad50 and 
Mre11 from T. maritima was a gift from A. Schele (Hopfner group): 
pET29b: tmRad50 [aa 1-190-GGAGGAGG-686-852; NdeI/NotI] tmMre116His/C-term [aa 343-385; NotI/     
Bpu1102I].  
 
Construct pRS313:scRad50 containing the wild-type Rad50 from S. cerevisiae with 477 bp 
upstream (promoter) and 291 bp downstream (terminator) regions: 
pRS313: scRad50 [full-length; XhoI/EcoRI]. 
 
Constructs derived from pET29b:tmRad50NBD-Mre11HLH and pRS313:scRad50 containing 
equivalent mutations in the Rad50 ORF are listed in Table 5. 
 
Table 5. Equivalent point mutations introduced into the Rad50 gene in pET29b:tmRad50NBD-
Mre11HLH and pRS313:scRad50 constructs. 
 
Mutation in tmRad50 Mutation in scRad50 
R2Q - 
R5Q - 
R9E - 
N10D - 
R94E K103E 
K95E K104E 
K99E Q115E 
K108E - 
K109E - 
K115E R131E 
K175E N190E 
K182E - 
R765E R1201E 
S768R S1205R 
E798Q 
R94E+K115E 
K95E+K115E 
E1235Q 
K103E+R131E 
K104E+R131E 
 
Construct for the end-joining activity assay containing kanMX cassette with 456 bp upstream 
(promoter) and 270 bp downstream (terminator) regions: 
pRS315:kanMX [full-length; SalI/BamHI]. 
Prior to end-joining experiments, 3 µg of pRS315:kanMX construct was linearized with 30 U of 
NcoI for 2 h at 37°C, followed by 20-minute enzyme inactivation at 80°C. 
 
 
Materials and methods 
 
30 
 
DNA used in in vitro assays 
Circular supercoiled and nicked plasmids (ΦX174 RF I and ΦX174 RF II, respectively) for 
EMSA were purchased from New England Biolabs. In order to prepare a circular relaxed species 
of the plasmid DNA, 1 µg of ΦX174 RF II was ligated with 10 U of T4 ligase for 12 hours at 
22°C. The ligase was then inactivated by 10-minute incubation at 65°C. Linearized plasmid 
species was prepared by enzymatic digest of 1 µg ΦX174 RF I with 20 U of EcoRI restrictase 
for 2 h at 37°C and subsequent 20-minute enzyme inactivation at 65°C.  
Blunt-ended dsDNA was prepared by annealing adequate oligonucleotides listed in Table 3. To 
this aim, oligonucleotides were mixed with annealing buffer (40 mM Tris pH 7.5, 100 mM NaCl, 
10 mM MgCl2), at 1.2 molar excess of fluorescently labelled oligonucleotide, preheated to 94°C 
and cooled down to 4°C at the rate of 0.1°C/s.  
 
Blunt-ended 200 bp DNA used for eliciting DNA damage response in Xenopus laevis egg extract 
was prepared in a PCR and purified by extraction from agarose gel. Samples were prepared 
according to the following protocol, with Phusion Flash Master Mix (Finnzymes, Espoo, 
Finnland), containing polymerase and deoxyribonucleotides: 
 
pBluescript SK+ II (template)     50-100 ng 98°C        1 min 
pBlue_For 50 µM                            0.5 µl 98°C        30 s 
pBlue_Rev 50 µM                            0.5 µl 52°C       20 s 
Phusion master mix                    10 µl 72°C            5 s 
H2O ad 20 µl 72°C          5 min 
    4°C        ∞ 
dsDNA used in crystallization experiments was prepared by annealing adequate oligonucleotides 
listed in Table 2. To this aim, oligonucleotides were mixed with annealing buffer (40 mM Tris 
pH 7.5, 100 mM NaCl, 10 mM MgCl2), at 1:1 molar ratio, preheated to 94°C and cooled down to 
4°C at the rate of 0.1°C/s.  
 
Strains (E. coli and S. cerevisiae) and cell lines 
Escherichia coli, Saccharomyces cerevisiae strains and insect cell lines used in this work are 
listed in Tables 6, 7 and 8, respectively. 
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Table 6. Escherichia coli strains used for molecular cloning and protein expression. 
 
E. coli strain genotype source 
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)]  
Stratagene, Heidelberg  
 
 
Rosetta (DE3)  
 
 
F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 
(CamR)  
 
Novagen, Madison, USA  
 
 
DH10MultiBac 
 
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔ  
M15 lacX74 recA1 endA1 araD139 (ara, 
leu)7697 galU galK Δ– rpsL nupG  
/pMON14272 / pMON7124  
 
Dr. Imre Berger  
Redbiotech, Schlieren, 
Switzerland  
 
 
Table 7. Saccharomyces cerevisiae strains used in in vivo assays. 
 
S. cerevisiae strain genotype source 
W303-1a Mata ade2-1 ura3-1  trp1-1  his3-11,15 leu2-
3,112 can1-100  rad5-535 
 
Dr. Boris Pfander,  
Max-Planck Institute for 
Biochemistry, Martinsried 
W303-1a ∆rad50 
 
rad50∆:TRP1 Mata  ade2-1  ura3-1  trp1-1  his3-
11,15  leu2-3 112  can1-100  rad5-535 
Dr. Stephen Jackson,  
Gurdons Institute, Cambridge 
 
Table 8. Insect cell lines used for baculovirus generation and protein expression. 
 
insect cell line origin source 
Sf21 clonal isolate derived from S. frugiperda  
 
Invitrogen, Karlsruhe 
HighFive clonal isolate derived from T. ni  Invitrogen, Karlsruhe 
 
Media and antibiotics 
Escherichia coli cultures (XL1 Blue and Rosetta) were grown in liquid LB (lysogeny broth) 
medium (1% (w/v) bacto-tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl) or on LB plates 
containing 1.5% (w/v) agar. Respective antibiotics were added to media to final concentrations: 
100 µg/mg ampicilin, 50 µg/ml kanamycin, 34 µg/ml chloramphenicol. 
Escherichia coli cultures (DH10MultiBac) were grown in 2xYT medium (yeast extract tryptone) 
(1.6% (w/v) bacto-tryptone, 1% (w/v) yeast extract, 0.5% (w/v) NaCl, pH 7.0) or on LB plates 
containing 0.1 mM IPTG, 50 µg/ml kanamycin, 10 µg/ml tetracycline, 10 µg/ml X-Gal and 7 
µg/ml gentamycin.  
Saccharomyces cerevisiae cultures (strains W303-1a and W303-1a ∆rad50) were grown in liquid 
YPD medium (yeast extract peptone dextrose; 1% (w/v) bacto-peptone, 1% (w/v) yeast extract, 
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2% (w/v) glucose) or on YPD plates containing 2% agar. These same strains transformed with 
pRS313 constructs were grown in synthetic SDC(-His) medium (Formedium, Hunstanton, UK) 
(0.675% (w/v) yeast nitrogen base without aminoacids, 0.06% (w/v) complete synthetic mix with 
all aminoacids except the auxotrophy marker histidine) or on SDC(-His) plates containing 2% 
agar.  
Sf21 insect cells were grown in Sf-900 III (GIBCO/Invitrogen, Karlsruhe) serum-free medium 
supplemented with 10 µg/ml gentamycin.  
HighFive insect cells were grown in Express Five (GIBCO/Invitrogen, Karlsruhe) serum-free 
medium prepared according to the manufacturer’s instruction and supplemented with 10 µg/ml 
gentamycin and 9.5 mM L-glutamine (GIBCO/Invitrogen, Karlsruhe).  
 
Antibodies 
Primary and secondary antibodies and their respective concentration used for immune-based 
detection of proteins are listed in Tables 9 and 10, respectively. 
 
Table 9. Primary antibodies and serum used for the immune-based protein detection and immuno-
depletion. 
 
primary antibody origin dilution source 
anti-Rad50,  
S.cerevisiae 
rabbit, polyclonal 1:4000 Dr. John Petrini, 
Memorial Sloan-Kettering Cancer Center, New 
York, USA 
anti-β-actin,  
human 
mouse, monoclonal 1:4000 Abcam (ab8224), Cambridge, UK  
 
anti-Mre11 serum, 
X. laevis 
rabbit, polyclonal 1:2000 Dr. Jean Gautier, 
Columbia University Medical Center, New York, 
USA 
anti-phosphorylated-
ATM (anti-P-ATM), 
human 
rabbit, polyclonal 1:1000 Abcam (ab979891) Cambridge, UK 
anti-α-tubulin, 
R. norvegicus 
mouse, monoclonal 1:6000 Sigma Aldrich (T8203), Munich 
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Table 10. Secondary antibodies used for the immune-based protein detection. 
 
secondary antibody origin dilution source 
anti-rabbit IgG-HRP goat, polyclonal 1:5000  
(in blots against xlMre11) 
1:10000  
(in blots against scRad50) 
Biorad (17-6515), Munich 
anti-mouse IgG-HRP sheep, polyclonal 1:5000 GE Healthcare (NA9310V), Munich 
 
3.2. Molecular biology methods 
Molecular biology procedures were carried out according to standard protocols unless otherwise 
stated. Commercially available kits and enzymes were used according to the manufacturer’s 
instructions. 
 
Molecular cloning 
Constructs carrying ORFs of single subunits of the human MRN complex were a gift from Dr. T. 
Paull (University of Texas, Austin, USA) and are listed in Table 11. 
 
Table 11. Constructs of the human MRN subunits (gift from T. Paull). 
 
construct name encoded ORF tag 
pTP hMre116His/C full-length 6xHis at C-terminus 
pTP hRad506His/C full-length 6xHis at C-terminus 
pTP hNbs1 full-length - 
 
These constructs were used to prepare pFBDM-based constructs for protein expression in insect 
cells. Primers listed in Table 1, introducing restriction sites and 6-histidine tag in case of the 
Nbs16His/C construct, were used to amplify full-length ORFs of Mre11, Rad506His/C, Nbs1 and  
Nbs16His/C according to the following PCR protocol: 
 
template     50-100 ng 98°C        1 min 
Forward primer 50 µM                                              0.5 µl 98°C        30 s 
Reverse primer 50 µM                                                   0.5 µl 56°C       20 s 
Phusion master mix                     10 µl 72°C           1 min/3 kb s 
H2O ad 20 µl 72°C          5 min 
    4°C        ∞ 
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PCR products and pFBDM vector were digested with adequate restriction enzymes. To prevent 
religation, the vector was dephosphorylated with 2 U of alkaline phosphatase per 1.5 µg vector 
for 30 min at 37°C. Ligation was performed with 2.5 U of T4 ligase at vector : insert molar ratio 
of 1:5 or 1:10, with 50-100 ng of vector, for 12 h at 22°C. Prior to transformation the ligase was 
inactivated for 20 min at 65°C.  
pFBDM:hMre11_hRad50 and pFBDM:hMre11_hRad506His/C constructs were prepared 
according to the above protocol by ligating pFBDM_hRad50 or ligating pFBDM_hRad506His/C 
with the digested PCR product of hMre11.  
pFBDM:hMre11_hRad506His/C_hNbs1 was prepared, using the multiplication cassette of the 
pFBDM vector. pFBDM:hNbs1 was digested with restrictases SpeI and BstZ17I and 
dephosphorylated. hMre11/hRad506His/C segment was excised from pFBDM: hMre11 
_hRad506His/C construct with PmeI and AvrII enzymes and ligated with pFBDM:hNbs1 due to 
compatibility of cohesive SpeI- and AvrII-generated ends and PmeI-/BstZ17I-generated blunt 
ends. Ligation was performed as described before at vector : insert molar ratio of 1:2.  
 
pET29b:tmRad50NBD_Mre11HLH construct was previously prepared by A. Schele (Hopfner 
group). TmRad50NBD was engineered by fusing the N-terminal (aa 1-190) and C-terminal (aa 
686-852) segments of Rad50 with an 8-aminoacid linker (GGAGGAGG) in a single ORF and 
cloning into pET29b with NdeI/NotI. TmMre11HLH motif (aa 343-385) with a 6-histidine tag at 
the C-terminus was cloned downstream of the Rad50NBD with NotI/Bpu1102I. 
 
pRS313:scRad50 construct was prepared by subcloning wild-type scRad50 ORF with promoter 
and terminator regions from pRS426:scRad50 construct (gift from H. Feldmann, Genzentrum 
LMU) to pRS313 vector with XhoI/EcoRI. 
 
pRS315:kanMX construct was prepared by subcloning kanMX cassette containing 456 bp 
upstream (promoter) and 270 bp  downstream (terminator) regions from pRS314:kanMX 
construct (gift from H. Feldmann, Genzentrum LMU) to pRS315 vector with SalI/BamHI. 
 
Site-directed mutagenesis 
In order to obtain point mutations in pET29b:tmRad50NBD_Mre11HLH  and pRS313:scRad50 
constructs, site-directed mutagenesis was performed in a single-step PCR with polymerase Pfu 
Ultra (Agilent, Waldbronn), according to the following protocol: 
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template     100-200 ng 94°C        5 min 
Forward primer 2 µM                                              0.5 µl 94°C        1 min 
Reverse primer 2 µM                                                   0.5 µl 56°C       1 min 
Pfu Ultra 10-fold buffer                      5 µl 68°C           2 min/1 kb 
dNTPs 10mM   1 µl 68°C          10 min 
Pfu Ultra 2.5 U/ µl   1 µl   4°C        ∞ 
H2O ad 50 µl   
 
After PCR, 20 U of DpnI restrictase was added to mutagenesis reaction, incubated 2 h at 37°C 
and inactivated 20 min at 80°C. 5 µl of the sample was the used to transform E. coli competent 
cells. Single colonies were picked for DNA amplification and purification. Mutations were 
confirmed by DNA sequencing (Eurofins MWG Operon, Ebersberg).  
 
Escherichia coli transformation 
Chemically competent E. coli (XL1 Blue and Rosetta strains) cells were transformed with 50-
100 ng of purified plasmid, 20 µl ligation sample or 5 µl mutagenesis sample. After 20-minute 
incubation on ice, cells were heat-shocked 45 s at 42°C and cooled down 2 min on ice. 600 µl of 
fresh LB medium was added and the cell suspension was incubated 1 h at 37°C. In case of 
transformation with purified DNA, 150 µl of cell suspension was plated on LB-agar medium 
containing appropriate antibiotic. In case of transformation with a ligation sample or mutagenesis 
sample, cells were first pelleted by brief centrifugation (4000 rcf, 2 min, RT), resuspended in 150 
µl of LB medium and plated. Colonies grew 12-16 h at 37°C.  
Chemically competent E .coli DH10MultiBac cells were transformed with 1.5 ug of purified 
plasmid and incubated 20 min on ice. Cells were heat-shocked 60 s at 42°C and cooled down 2 
min on ice. 1 ml of fresh 2xYT medium was added and the cell suspension was incubated 16 h at 
37°C. 20-100 µl of the cell suspension were next plated and incubated for 48-72 h at 37°C. In 
order to confirm that the colonies contained recombinant backmid (baculoviral DNA), white 
cells were restreaked on fresh plates and if the white color was preserved (i. e. recombination of 
the ORFs of interest into bacmid was successful), used further for backmid isolation. 
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3.3. Protein biochemistry methods 
Protein expression in E. coli 
Recombinant protein expression was performed in E. coli Rosetta (DE3) strain transformed with 
pET29b:tmRad50NBD_Mre11HLH carrying wild-type or mutated Rad50 ORF. Cells were grown in 
LB media under aerobic conditions (150 rpm, 37°C) to an OD600 of 0.6-0.8. Protein expression 
was induced with 0.2 mM IPTG and carried out at 18°C overnight. Cells were harvested by 
centrifugation (5000 rcf, 15 min, 4°C) and submitted to further purification steps or frozen in 
liquid nitrogen and stored at -80°C until further use.  
 
Protein expression baculovirus-infected insect cells  
Baculovirus preparation in Sf21 cells 
Bacmids containing ORFs of the MRN complex or its subunits were used to generate 
baculovirus particles able to infect and drive protein expression in insect cells. First, 2 ml of Sf21 
cells at density 0.4x106 cells/ml were incubated at 27.5°C in 6-well culture plate. Transfection 
solution was prepared by mixing 200 µl medium, 3 µl transfection agent (FuGene, Promega, 
Mannheim) and 1-2 µg bacmid DNA. After the cells had attached to the bottom of the culture 
well, transfection solution was added. As a control, cells mixed with a transfection solution 
without bacmid was also prepared. Cells were further incubated for 72-84 h at 27.5°C, giving 
rise to the first generation of the baculovirus (P1). 1 ml of medium containing P1 virus was 
added to 10 ml Sf21 cell suspension at density 1x106 cells/ml and cultured for 72-84 h (95 rpm, 
27.5°C). After incubation, cells were monitored under a light microscope (viability, 
morphology). In case of evident infection, cells were pelleted (3000 rcf, 10 min, RT), virus-
containing medium was filtered (generation P2) and used to rise final P3 generation. To this end, 
100 µl of P2 virus were added to 100 ml of Sf21 cell suspension at density 0.4x106 cells/ml and 
incubated for 72 h (95 rpm, 27.5°C). After incubation, the culture was again monitored for 
viability and morphology. Infected cells were pelleted (3000 rcf, 10 min, RT), virus-containing 
medium was filtered (generation P3) and stored at 4°C.  
 
Protein expression in HighFive cells 
In order to determine the amount of the virus required for efficient protein expression, small-
scale expression tests were performed. To this end, 10 ml HighFive cell suspension at density 
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1x106 cell/ml were infected with 0 (control culture), 10, 20 50 and 200 µl of P3 baculovirus. 
After 72-hour incubation (95 rpm, 27.5°C) cells were monitored for viability and morphology. 
Protein expression was determined by whole-cell SDS-PAGE analysis. The optimal amount of 
P3 baculovirus for subsequent large-scale experiments was the lowest volume that still induced 
protein expression. 
hMRN complex was expressed in 500 ml fresh cell suspension. Cells were cultured for 72 h (95 
rpm, 27.5°C), pelleted (3000 rcf, 15 min, RT), frozen in liquid nitrogen and stored at -20°C until 
further use. 
 
Protein purification  
tmRad50NBD-Mre11HLH 
Cells were resuspended in Lysis buffer and disrupted by sonication. Lysate was cleared by 
centrifugation (20000 rcf, 30 min, 4°C), incubated 10 min at 65°C to denature E. coli 
endogenous proteins and again cleared by centrifugation (15000 rcf, 15 min, 4°C). Lysate was 
applied on Ni-NTA affinity chromatography resin in a gravity-flow column. Resin was washed 
with 2 CV of Lysis buffer and 1 CV of Wash buffer. Protein was eluted with Elution buffer, 
concentrated and subjected to gel filtration. Fractions corresponding to the monomeric species 
were collected, concentrated to 60-80 mg/ml, frozen in liquid nitrogen and stored at -80°C. All 
mutants of tmRad50NBD-Mre11HLH were purified according to this protocol. Table 12 lists buffers 
used in tmRad50NBD-Mre11HLH preparation. 
 
Table 12. Buffers for purification of the recombinant tmRad50NBD-Mre11HLH complex. 
 
Lysis buffer Wash buffer Elution buffer Gel filtration buffer 
25 mM Tris pH 8.0 25 mM Tris pH 8.0 25 mM Tris pH 8.0 5 mM Tris pH 7.8 
300 mM NaCl 1.5 M NaCl 100 mM NaCl 200 mM NaCl 
10 mM imidazole 20 mM imidazole 150 mM imidazole  
 
hMRN 
Recombinant human MRN complex was purified similarly to the previously reported protocol 
(Paull and Gellert 1998, 1999). Cell pellet was resuspended in Lysis buffer supplemented with 
complete mix of protease inhibitors (Roche, Penzberg). Cell suspension was brefly sonified and 
centrifuged (25000 rcf, 45 min, 4°C). Cell lysate was sonified again, filtered and applied on Ni-
NTA resin. After complete migration of the lysate through the column upon gravity flow, the 
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resin was washed with 2 CV of Lysis buffer and 5 CV of Wash buffer. The complex was eluted 
with Elution buffer, dialysed to Buffer A, applied on MonoQ column and eluted with 12 CV 
gradient of 50-500 mM NaCl. Fractions containing MRN complex were pulled together, 
concentrated and applied on gel filtration column Superose 6. Fractions containing MRN 
complex were again pulled together, concentrated to approximately 5 mg/ml, frozen in liquid 
nitrogen and stored at -80°C. Table 13 lists buffer used in hMRN preparation. 
 
Table 13. Buffers for purification of the recombinant hMRN complex 
Lysis buffer Wash buffer Elution buffer Buffer A Gel filtration buffer 
50 mM  
Na phosphate pH 7.0 
50 mM  
Na phosphate  pH 7.0 
50 mM  
Na phosphate pH 7.0 
20 mM Tris  
pH 8.0 
20  mM Tris  
pH 8.0 
500 mM NaCl 500 mM NaCl 500 mM NaCl 50 mM NaCl 500 mM NaCl 
10 mM imidazole 20 mM imidazole 100 mM imidazole 0.05% (v/v) 
Tween20 
0.1% (v/v) 
Tween20 
0.5% (v/v) Tween20 0.5% (v/v) Tween20 0.5% (v/v) Tween20 10% ( v/v)  
glicerol 
10% (v/v) glicerol 
10% (v/v) glicerol 10% (v/v) glicerol 10% (v/v) glicerol 1 mM DTT 1 mM DTT 
20 mM 2-ME 20  mM 2-ME 20 mM 2-ME   
 
SDS-PAGE analysis 
Protein samples were analyzed in vertical SDS-polyacrylamide gel electrophoresis system 
according to Laemmli (Laemmli 1970). 15% acrylamide in the separating gel was used for 
analysis of tmRad50NBD-Mre11HLH samples, whereas hMRN samples were separated in 10% 
acrylamide gels.  
Samples were mixed with Sample buffer and incubated 5 min at 90°C. Electrophoresis was 
performed at 200-220 V in Running buffer. Next, gels were stained in Staining solution and 
destained with deionised water. To determine approximate protein weight, a molecular weight 
marker was used (PageRuler Prestained 26616 and PageRuler Unstained 26614 from Thermo 
Scientific for analyses of hMRN and tmRad50NBD-Mre11HLH, respectively; PageRuler Prestained 
26616 from Thermo Scientific and Dual Color 161-0374 from Biorad for Western blot analyses 
of yeast samples and X. laevis egg extract samples, respectively). Table 14 lists buffers used for 
sample preparation and SDS-PAGE electrophoresis.  
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Table 14. Buffers used for the SDS-PAGE analysis. 
 
4-fold Sample buffer Running buffer Staining solution 
110 mM Tris pH 6.8 25 mM Tris  7% (w/v) acetic acid 
16% glycerol 192 mM glycine 50% (w/v) EtOH 
4% (w/v) SDS 
5% 2-ME 
0.1% (w/v) SDS 0.2% (w/v) Coomassie Brilliant 
Blue R-250 
0.6% bromphenolblue   
 
Dimetrization of tmRad50NBD-Mre11HLH  
Dimerization of the monomeric tmRad50NBD-Mre11HLH complex was initiated by addition of 
AMPPNP. Protein was mixed with AMPPNP to final concentration of 20 mg/ml protein and 5 
mM AMPPNP in dimerization buffer and incubated at 8°C. Dimerization was monitored by 
analytical gel filtration after 1, 5, 24, 48 and 72 h after reaction start. The process was very fast 
(for wild-type protein and most mutants it reached the maximal dimerization efficiency already 
between 1-5 h) but for practical reasons protein was always dimerized for 24 h prior to in vitro 
activity assays. Table 15 lists stocks and buffers used for preparation of dimerized tmRad50NBD-
Mre11HLH species.  
 
Table 15. Stocks and buffer used for tmRad50NBD-Mre11HLH dimerization. 
 
monomeric protein stock ANPPNP stock Dimerization buffer 
60-80 mg/ml 50 mM in 100 mM Tris pH 7.5 5 mM Tris pH 7.8 
  100 mM NaCl 
  5 mM MgCl2 
 
Analytical gel filtration 
Protein homogeneity and dimerization efficiency was monitored by analytical gel filtration. 
Dimerization mix was first diluted to protein final concentration of 8 mg/ml, injected on 
Superdex s200 5/150 column and eluted in the running buffer containing 5 mM Tris pH 7.8, 100 
mM NaCl and 5 mM MgCl2.   
 
Western blot analysis 
S. cerevisiae samples 
TCA-precipitated whole-cell yeast lysates were first subjected to SDS-PAGE analysis in 8% 
acrylamide gels and then blotted onto nitrocellulose membrane (Roth) in Transfer buffer with 
20% EtOH and 0.1% (w/v) SDS. Transfer was carried out at 200 mA for 1 h at 8°C. The 
Materials and methods 
 
40 
 
membrane was then blocked in TBST buffer supplemented 5% milk for 1 h at RT. Incubation 
with the primary antibody (anti-Rad50 and anti-α-actin as loading control) was performed 
overnight at 8°C in TBST buffer with 5% milk. Next, the membrane was washed with TBST 
buffer (3 x 10 min) and incubated with a HRP-conjugated secondary antibody in TBST for 1 h at 
RT. Finally, the membrane was washed in TBST buffer (3 x 15 min) and immunostained 
proteins were detected by adding HRP substrate solution and subsequent exposure with a light 
sensitive Hyperfilm™ ECL™ (GE Healthcare).  
 
X. laevis samples 
Xenopus laevis egg extract samples were first subjected to SDS-PAGE analysis in 4-12% 
gradient Bis-Tris gel (Criterion, Biorad) in XT buffer (Biorad) and blotted onto PVDF membrane 
(Millipore) in 2-fold Transfer buffer with 20% EtOH and 0.05% (w/v) SDS. Transfer was 
performed at 250 mA for 2 h at 8°C. The membrane was next blocked in TBST supplemented 
with 5% milk for 1 h at RT, washed with TBST (3 x 15 min) and incubated with the primary 
antibody (anti-P-ATM and anti- α-tubulin as loading control) in TBST overnight at 8°C. After 
washing with TBST (3 x 15 min), the membrane was incubated with HRP-conjugated secondary 
antibody in TBST for 1 h at RT and washed again with TBST (3 x 15 min). Immunostained 
proteins were detected by adding HRP substrate solution and subsequent exposure with a light 
sensitive Hyperfilm™ ECL™ (GE Healthcare). Table 16 lists buffers and solutions used for 
Western blot analysis. 
 
Table 16. Buffers for the Western blot analysis. 
 
Transfer buffer TBST buffer HRP substrate solution 
25 mM Tris 20 mM Tris pH 7.4 100 mM Tris pH 8.5 
195 mM glycine 150 mM NaCl 225 uM coumaric acid 
 0.1% (v/v) Tween20 1.25 mM luminol 
  0.009% (w/v) H2O2 
 
Electrophoretic mobility shift assay 
With plasmid DNA 
DNA-binding properties of the wild-type tmRad50NBD-Mre11HLH were analysed in 
electrophoretic mobility shift assay (EMSA). Increasing amount of dimerised protein (0, 71.5 
nM, 357.5 nM, 715 nM, 1.43 µM, 3.57 µM, 7.15 µM, 14.3 µM, 28.6 µM and 57.2 µM) was 
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incubated with plasmid DNA (7.15 nM) in 5 mM Tris pH 7.8, 100 mM NaCl, 5 mM MgCl2 in a 
total volume of 20 µl for 15 min on ice. The reaction samples were next mixed with loading 
buffer (6-fold loading buffer: 10 mM Tris pH 7.8, 16% (v/v) glycerol, 0.03% (w/v) bromphenol 
blue, 0.03% (w/v) xylene cyanol) and separated in 0.5% agarose gel in TA buffer (40 mM Tris, 
20 mM acetic acid) for 3.5 h at 80 V and 8°C. Protein-DNA complexes were stained with DNA-
intercalating agent GelRed and visualized by UV Imaging System (Intas). Four different plasmid 
species were used in that assay: circular nicked relaxed ΦX174 RF II, circular intact relaxed 
ΦX174 RF II, circular supercoiled ΦX174 RF I and linearized ΦX174 RF I. 
DNA-binding by mutants of tmRad50NBD-Mre11HLH was analyzed with circular nicked relaxed 
ΦX174 RF II, according to the above protocol. 
 
With short dsDNA 
Increasing amounts of dimerised tmRad50NBD-Mre11HLH (0, 125 nM, 250 nM, 375 nM, 625 nM, 
1.25 µM, 2.5 µM, 5 µM and 12.5 µM) were incubated with 25 nM 30 and 60 bp blunt-ended and 
fluorescently labelled DNA in 5 mM Tris pH 7.8, 100 mM NaCl, 5 mM MgCl2 in a total volume 
of 10 µl for 15 min on ice.  
Reaction samples were next mixed with loading buffer (6-fold loading buffer: 10 mM Tris pH 
7.8, 16% (v/v) glycerol, 0.03% (w/v) bromphenol blue, 0.03% (w/v) xylene cyanol) and 
separated in 8% poliacrylamide native gel in TA buffer (40 mM Tris, 20 mM acetic acid) for 1-
1.5 h at 100 V and 8°C. Protein-DNA complexes were visualized with a Typhoon System 
(Amersham Biosciences) using the green-excited (488 nm) fluorescence mode. 
Similar reaction was performed with 60 bp intact and 60 bp nicked DNA, but at DNA 
concentration of 50 nM and increasing protein concentrations of 0, 1.25 µM, 2.5 µM, 5 µM, 10 
µM, 12.5 µM, 25 µM, 50 µM and 100 µM. 
 
3.4. Structural biology methods 
Crystallization and crystal freezing 
Prior to screening and refinement, tmRad50NBD-Mre11HLH protein was mixed with ANPPNP and 
DNA stocks, giving crystallization mix of 12 mg/ml protein, 5 mM AMPPNP and 3.5-5 molar 
excess of DNA. First screenings were performed in 96-well plates, using commercially available 
crystallization screens. Refinements of the initial condition (0.15 M D-maleic acid, 20% (w/v) 
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PEG3350) were performed in 24-well plates by the hanging drop vapor diffusion method, 
diluting 1 µl of the crystallization mix with 1 µl of the mother liquor and closing the drop over 
400 µl-reservoir with the mother liquor. During refinement varying pH values and PEG3350 
content were used. Crystals of tmRad50NBD-Mre11HLH-DNA were grown at 20°C. They appeared 
after 24 h and grew further for the next 7-10 days. At that point, they were fished and frozen in 
liquid nitrogen under cryoprotective conditions, containing mother liquor with 20-25% (v/v) 
glycerol or 15% (v/v) L-(+)-2,3-butanediol.  
 
Data collection  
Diffraction data were collected at beamlines ID-29 and BM-30 at European Synchrotron 
Radiation Facility (ESRF, Grenoble, France) or at X06SA beamline at Swiss Light Sourse 
synchrotron (SLS, Villigen, Switzerland). Most crystals formed space group P2(1) with one 
dimeric molecule per asymmetric unit and cell dimensions: a=49.8 Å, b=106.0 Å, c=93.9 Å, 
α=90°, β=98.3°, γ=90°. Crystal that yielded the final structure formed space group P1 with two 
dimeric molecules per asymmetric unit and cell dimensions: a=50.2 Å, b=107.6 Å, c=97.1 Å, 
α=90.6°, β=98.3°, γ=89.4°. Data processing was performed with XDS software (Kabsch 1993).  
 
Structure determination, model building and refinement 
The structure was determined first by molecular replacement with Phaser (McCoy et al. 2007), 
using the tmRad50NBD-Mre11HLH apo structure as a search model (PDB entry: 3QF7). The initial 
model was rebuilt manually in COOT (Emsley and Cowtan 2004) and refined in Phenix (Adams 
et al. 2002). At early stage of manual building and refinement, a 15 bp DNA molecule was 
manually build into the difference density and the model was subjected to rigid-body refinement 
constrained to the built-in DNA.  Further refinements included interative cycles of bulk solvent 
corrections, overall B-values, positional and B-factor, TLS refinement and manual building. 
Prior to refinement, 5% of the reflections were randomly omitted to monitor the Rfree value.  
All figures of structural models were prepared with PyMOL (DeLano Scientific).  
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3.5. Yeast specific methods 
Yeast transformation with pRS313:scRad50 constructs 
3 ml of YPD medium were inoculated with one loop of S. cerevisiae W303-1a (wild-type) or 
W303-1a ∆rad50 and grown overnight (155 rpm, 30°C). In the morning next day cultures were 
diluted 1:5 or 1:10 in 3 ml of fresh medium and grown further for 3-4 h until OD600 of 1-2 was 
reached. Cells were pelleted by centrifugation (4000 rcf, 1 min, RT) and resuspended in 100 µl 
Solution 1 (10 mM Tris pH 7.4, 100 mM lithium acetate). 3 µg of respective construct was 
premixed with 10 µl of salmon sperm DNA (10 mg/ml stock) and added to the cell suspension. 
Next, 500 µl of Solution 2 (10 mM Tris pH 7.4, 100 mM lithium acetate, 50% (w/v) PEG3350) 
was added, vortexed and rotated 30 min at RT on a turning wheel. Cell suspension was next 
subjected to 10-minute heat-shock step at 42°C. After a 2-minute incubation on ice, cells were 
pelleted by centrifugation (4000 rcf, 1 min, RT), resuspended in 100 µl of deionised water and 
plated on SDC(-His)-agar medium. Plates were incubated 72 h at 30°C.  
 
Plate survival assay 
3 ml of SDC(-His) medium were inoculated with a single colony of S. cerevisiae W303-1a or 
W303-1a ∆rad50 transformed with pRS313 constructs and grown overnight (155 rpm, 30°C). 
Cultures were diluted in deionised water to OD600 of 1 and serial 10-fold dilutions in water were 
prepared (100-10-5). 4 µl of each dilution were plated on SDC(-His)-agar medium supplemented 
with DNA-damaging agents: 0.005% MMS or 1 µg /ml CPT or 50 mM HU. Cells were 
incubated at for 72 h at 30°C. Experiment was performed in triplicates. 
 
Sample preparation for Western blot analysis 
TCA-precipitated whole-cell yeast lysates for Western blot analysis were prepared according to a 
modified protocol based on Yaffe and Schatz (Yaffe and Schatz 1984). 20 OD units of an 
overnight yeast culture were centrifuged and the cell pellet was washed with 1 ml deionised 
water. Cells were lysed at RT with 1.5 ml Solution 1 (200 mM NaOH, 1% 2-ME) and vortexing. 
150 µl 50% (w/v) TCA was added, cell were vortexed again, incubated for 10 min on ice and 
centrifuged (16000 rcf, 10 min, 4°C). Pellet was washed with 1.5 ml acetone and incubated 5 
min on ice. After centrifugation (16000 rcf, 5min, 4°C), pellet was resuspended in 25 µl of 2-fold 
Sample buffer (Table 13), sonified in a bath sonicator for 2 min and incubated 5 min at 90°C. 
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The samples were centrifuged again (16000 rcf, 5min, 4°C) and 6 µl of the supernatant was 
submitted to SDS-PAGE and subsequent Western blot analysis.  
 
Analysis of end-joining activity 
20 ml of SDC(-His) medium were inoculated with a full loop of S. cerevisiae W303 1a-WT 
(wild-type) or W303-1a ∆rad50 transformed with pRS313 constructs and grown overnight (155 
rpm, 30°C). Next day morning cultures were diluted in 100 ml of fresh YPD medium to OD600 of 
0.1-0.2 and grown further for 4-6 h until OD600 of 0.6-0.8 was reached. Cells were pelleted (3000 
rcf, 20 min, RT), washed with 50 ml of deionised water, pelleted again (3000 rcf, 20 min, RT) 
and resuspended in 2 ml of 100 mM lithium acetate. Cells were again harvested by centrifugation 
(16000 rcf, 15 s, RT) and resuspended in 200 µl of 100 mM lithium acetate. 100 µl of this cell 
suspension was centrifuged (5000 rcf, 1 min, RT), supernatant was discarded and the cells were 
mixed with 240 µl of 50% (w/v) PEG3350, 36 µl 1 M lithium acetate, 54 µl deionised water and 
3 µg of supercoiled or linearized pRS315:kanMX construct, vortexed and incubated 30 min at 
30°C prior to 25-minute heat-shock step at 42°C. After brief incubation on ice, cells were 
pelleted (6000 rcf, 1 min, RT), resuspended in 1 ml of deionised water. 100 µl of the cell 
suspension were plated on SDC(-His, -Leu)-agar medium and incubated for 72 h at 30°C. 
Experiment was performed in triplicates.  
Colonies were counted; the average number of colonies formed by cells transformed with the 
linearized plasmid was normalized against the average number of transformants with the 
supercoiled plasmid. Error was calculated using the relative standard deviation method. 
 
Analysis of telomere length (assay performed by Dr. H. Feldmann, Gene Center, Munich) 
Genomic DNA was isolated from 100 ml overnight S. cerevisiae culture at OD600=1.5-2.0. 1 µg 
of the DNA was digested with 10 U XhoI overnight at 37°C and analysed on 1% agarose gel in 
TAE  buffer (Tris-acetate-EDTA buffer; 40 mM Tris, 20 mM acetic acid, 1 mM EDTA). DNA 
was subsequently blotted onto nitrocellulose membrane and hybridized with a [32P]-labelled 
poly(GT)20 probe in Church buffer (7% SDS, 1% BSA, 250 mM Na2HPO4, 1 mM EDTA) 
overnight at 60°C. Blots were washed in 0.2-fold SSC buffer (saline-sodium citrate buffer, 1-
fold: 15 mM trisodium citrate pH 7.0, 150 mM NaCl) supplemented with 0.1 % SDS for 20 min 
at RT. DNA was visualized by autoradiography. 
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3.6. Xenopus laevis specific methods  
Egg extract preparation and monitoring 
Interphase Xenopus laevis egg extracts were prepared according to a modified protocol based on 
Kubota (Kubota and Takisawa 1993). Eggs derived from hormonally primed female frogs were 
collected and washed with 100 mM NaCl. Approximately 50 ml of eggs were used to prepare 
one batch of egg extract. Eggs were dejellied in 50 ml Buffer D supplemented with 5 mM DTT 
(10 min, RT), washed with 1/4 MMR buffer (3 x 50 ml) and activated with 2 µl calcium 
ionophore for 5 min. Eggs were washed again with 1/4 MMR buffer (3 x 50 ml) and then with 
ice-cold buffer S (3 x 50 ml) supplemented with 10 µg/ml leupeptin in the last step. Washed eggs 
were transferred to 2 ml eppendorf tubes and packed by brief centrifugation (2000 rcf, 45 s, 
4°C). Buffer excess was discarded and eggs were crushed by centrifugation (16000 rcf, 12 min, 
4°C). Cytoplasmatic fraction was collected, mixed with cytochalasin B to final concentration of 
40 µg/ml and centrifuged again (70000 rcf, 12 min, 4°C). Cytoplasmatic and membrane fractions 
were collected, mixed with glycerol to final concentration of 1%, frozen in 20 µl aliquots in 
liquid nitrogen and stored in liquid nitrogen. 
In order to check if prepared extracts were indeed arrested in interphase, replication activity was 
monitored. To this end, 20 µl of the extract was mixed with creatin phosphate (final 
concentration 30 mM), creatin phosphor kinase (final concentration 150 µg /ml), cyclohexamide 
(final concentration 40 µg/ml), Cy3-dCTP (final concentration 1 µM) and demembrated sperm 
nuclei (final concentration 3000 nuclei/ µl) and incubated at 23°C. 3 µl of this reaction were 
mixed with 3 µl FIX buffer and monitored for replication at time point 0, 30 and 60 min. Extract 
that supported replication were used for subsequent experiments. Table 17 lists buffers and 
reagent stocks used for egg extract preparation and handling. 
 
Table 17. Buffers and stocks used for X. laevis egg extract preparation. 
 
Buffer D Buffer MMR Buffer S FIX buffer 
10 mM Tris pH 8.5 20 mM Hepes-KOH pH 7.5 50 mM Hepes-KOH pH 7.5 25 mM Hepes-KOH pH 7.8 
110 mM NaCl 400 mM NaCl 50 mM KCl 25 mM KCl 
 2 mM KCl 2.5 mM MgCl2 1.25 mM MgCl2 
 1 mM MgSO4 250 mM sucrose 18% glycerol 
 2 mM CaCl2  3 µg/ml Hoechst 
 0.1 mM EDTA   
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calcium ionophore 10 mM stock in DMSO 
cytochalasin B 10 mg/ml stock in DMSO 
creatin phosphate 1 M stock in deionised water 
creatin phosphor kinase 10 mg/ml stock in deionised water 
cyclohexamide 
 
10 mg/ml stock in deionised water 
Immunodepletion of MRN complex 
In order to remove endogenous MRN complex from egg extract, anti-xlMre11 serum was used 
(gift from J. Gautier). 25 µl of the serum was first incubated with 40 µl 50% (v/v) Protein-A 
Sepharose slurry (GE, Healthcare) in PBS for 1 h at RT on a turning wheel (15 rpm). The beads 
were then washed (3 x 400 µl of PBS), divided and transferred to 3 new eppendorf tubes for 
subsequent 3 round of immundepletion. Protein-A beads for mock depletion were prepared as 
described above but PBS was used instead of the serum. 50 µl of egg extract was incubated three 
times with aliquots of antibody bound beads (or free beads for mock extract preparation). 
Incubation was performed for 45, 30 and 30 min at 4°C on a turning wheel (4 rpm). Extract was 
separated from the beads and the efficiency of immunodepletion was monitored by Western blot 
analysis.   
 
DNA-induced ATM phosphorylation 
Immunodepleted and mock extracts were used to check DNA damage response. To this end, 9.5 
µl of the extract was mixed with 0.5 µl DNA stock (200 bp blunt-ended DNA, 35 ng/µl) and 
incubated at 23°C for 0, 2, 5, 10, 15 and 30 min. At each time point, 0.5 µl of the reaction was 
taken to prepare an SDS-PAGE sample. Subsequently, samples were separated in SDS-PAGE 
(Criterion, Biorad), blotted and immunostained against phosphorylated ATM.  
 
Rescue of ATM signalling in MRN-depleted extract 
Recombint hMRN complex, expressed in insect cells was previously shown to rescue DNA 
damage response in MRN-depleted egg extracts (Costanzo et al. 2001). In this work, an attempt 
to reproduce this experiment was undertaken, using wild-type hMRN preparation and in case this 
was successful, further experiments were to be performed with hMRN mutants. 
Immunodepleted and mock-depleted extracts were preincubated with 1 or 2 µl of recombinant 
hMRN (5.8 mg/ml) for 15 min at 23°C. As a control, extract were also mixed with hMRN 
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storage buffer. Next, 0.5 µl of DNA was added and samples for SDS-PAGE were prepared at 
timepoints 0, 15, 30 and 60 min.  ATM-phosphorylation was monitored as the readout of 
DNAdamage response. 
 
3.7. Bioinformatic methods 
Sequence alignments of Rad50 orthologues were performed with the program ClustalOmega, 
available online: http://www.ebi.ac.uk/Tools/msa/clustalo/ (Sievers et al. 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
48 
 
4. Results 
4.1. Preparation of the Rad50NBD-Mre11HLH complex from T. maritima 
Previous attempts of crystallizing longer T. maritima and P. furiosus MR complexes with DNA 
were unsuccessful (work of C. Möckel, Hopfner group). For this reason, a minimal part of the 
protein complex, containing the Rad50 ATPase domain (NBD, nucleotide-binding domain) 
together with a short helix-loop-helix Rad50-interacting motif of Mre11 (tmRad50NBD-
Mre11HLH), was used for further studies and crystallization trials.  
4.1.1. Cloning and purification 
Construct containing catalytic head of tmRad50 and a short peptide of tmMre11 was a gift from 
A. Schele (Hopfner group). In this construct, the bipartite N- and C-terminal segments of the 
Rad50 NBD together with the adjacent coiled-coil domain (residues 1-190 and 687-852) were 
fused via a flexible linker GGAGGAGG. A short helix-loop-helix motif of Mre11 (residues 347-
385), encompassing the very C-terminal part of the protein and carrying a polyhistidine C-
terminal tag was cloned downstream to the Rad50 ORF. It was shown before that one of the 
interaction interfaces between Mre11 and Rad50 relies on a strong hydrophobic interaction 
between the root of the coiled-coil domain and the HLH motif of Mre11 (Lammens et al. 2011). 
This hydrophobic patch on the Rad50 coiled-coil, if remained unoccupied, could potentially 
influence solubility of the recombinant protein. Therefore, the construct design included the 
helix-loop-helix motif of Mre11, assuming it would render Rad50 more stable and soluble 
(Figure 10).  
                
 
Figure 10. Construct preparation and purification of tmRad50NBD-Mre11HLH. Left panel: construct 
design of the tmRad50NBD-Mre11HLH catalytic head; BS: binding site. Right panel: SDS-PAGE analysis of 
the tmRad50NBD-Mre11HLH purification on Ni-NTA resin (1: cells before induction, 2: cells after 
induction, 3: pellet, 4: cleared cell lysate, 5: cleared lysate after heat step, 6: flow-through, 7: wash 1, 8: 
wash 2, 9: elution). Due to the small size of Mre11HLH only Rad50NDB is detectable. 
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The complex was recombinantly co-expressed in E. coli. Subsequent purification and 
crystallization revealed that both proteins were interacting very stably, even if high 
concentrations of salt were used (up to 1.5 M NaCl during purification). The MR complex eluted 
from the Ni-NTA resin was directly applied on the gel filtration column. Interestingly and in 
contrast to recombinant eukaryotic orthologues, the gel filtration profile showed that the complex 
migrated predominantly as a monomeric species (including one Rad50 molecule and one Mre11 
HLH motif), with only a minor fraction forming a dimer (Figure 11).  
 
 
 
Figure 11. Elution profile of tmRad50NBD-Mre11HLH in gel filtration. Small fraction of the protein 
forms a dimer, the rest remains in a monomeric form. Due to the small size of tmMre11HLH only 
tmRad50NDB is detectable on the SDS-PAGE gel. 
 
Heterologous expression of the tmRad50NBD-Mre11HLH complex was very efficient, with an 
average yield of 12 mg of protein per 1 g of cells.  
4.1.2. Dimerization 
Prior to crystallization and biochemical analyses, the monomeric tmRad50 carrying the tmMre11 
HLH motif was dimerized, to assure correct formation of the bipartite ATPase domains. To this 
end, tmRad50NBD-Mre11HLH was incubated with AMPPNP. The reason to use AMPPNP was to 
avoid subsequent hydrolysis and opening of the complex as it was suggested before (Lammens et 
al. 2011).  
Dimerization efficiency was monitored over time with gel filtration. As expected, the protein 
dimerized very efficiently; most of the protein formed a dimeric species between 1-5 h after 
addition of AMPPNP, with an average efficiency of approximately 85%. This dimeric form was 
stable over time at least until 96 h after addition of AMPPNP. Even though a high excess of 
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AMPPNP was used to induce dimerization, the protein was never completely dimerized, leaving 
about 15% in a monomeric state (Figure 12).  
 
 
 
Figure 12. AMPPNP-induced dimerization of tmRad50NBD-Mre11HLH. As monitored in gel filtration, 
in the absence of AMPPNP the protein remains in a monomeric form (blue line). Addition of AMPPNP 
and Mg2+ results in a dimer formation (red line). 
 
4.2. Crystal structure of tmRad50NBD-Mre11HLH with DNA 
4.2.1. Crystallization and structure determination 
In order to gain structural insight into the Rad50-DNA complex formation, tmRad50NBD-
Mre11HLH was crystallized with DNA. To this end, monomeric tmRad50NBD-Mre11HLH was 
mixed with short dsDNA of varying lengths (13 bp, 15 bp, 15 bp with 1 nt overhang, 17 bp and 
21 bp) and AMPPNP and screened against various conditions. AMPPNP was used instead of 
ATP in order to prevent hydrolysis and subsequent dimer dissociation (Lammens et al. 2011). 
Other non-hydrolyzable ATP analogs were not tested, as it had been observed before that the 
protein behaviour was better with AMPPNP than with ATPγS (C. Möckel, personal 
communication). 
Four initial hits were further optimized in the refinement steps and macroscopically good-quality 
crystals were subjected to X-ray diffraction experiments. Initial data analysis, including structure 
determination by molecular replacement with the apo tmRad50NBD-Mre11HLH model (PDB entry: 
3QF7) showed that most of these crystals did not contain DNA and therefore were not further 
refined and processed. 
DNA-containing crystals appeared with 15 bp-DNA with 1 nt overhang in a crystallization 
condition containing 150 mM D-malic acid pH 7.0 and 20% (w/v) PEG3350. They were refined 
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against pH and PEG3350 concentration. It turned out that bigger and more numerous crystals 
grew preferentially in acidic pH between 5 and 6 and at PEG3350 concentrations varying 
between 19-22% (Figure 13).  
 
 
 
Figure 13. Crystals of tmRad50NBD-Mre11HLH -DNA (A and B) and their diffraction pattern (C). 
Crystals formed big intergrown and fragile plates of a highly irregular shape. 
 
Processing of the diffraction data collected from these crystals revealed that the electron density 
accounted for DNA was not very clear. Although the overall geometry and shape of this positive 
difference density resembled DNA shape, it was difficult to trace the sugar-phosphate backbone 
and many of the bases were not visible.  
In order to find out if the data quality could be improved, refinement screens with a higher molar 
excess of DNA were performed. Simultaneously, other DNAs were tested (13 bp, 17 bp, 19 bp, 
21 bp). Unfortunately, these modifications did not bring any improvement to the diffraction 
quality and the recurring problem of the poor density for the DNA was due to the flexibility of 
the DNA molecule, rather than insufficient saturation of the protein with DNA. Other DNA 
species had only negative effect on the crystal quality. 13 bp and 21 bp DNA failed to yield any 
crystals whereas 17 bp and 19 bp DNA formed crystals of extremely poor order. As a 
consequence, very few of them showed any diffraction and these datasets failed during 
processing. 15 bp DNA with 1 nt overhang was therefore chosen for further refinements. 
Since the 1 nt overhang of the DNA was not recognizable in the positive difference density, it 
was difficult to assign the base pair registry. Therefore, a modified DNA was used, containing 
one bromouracil instead of a thymine. Bromouracil is structurally similar to thymine; it also pairs 
with adenine and therefore can be used to mimic thymine (Figure 14). At the same time, the 
bromine atom should give an anomalous signal recognizable in the density and help to assign the 
registry and sequence of the DNA.  
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Crystals with the brominated DNA appeared in the same conditions that yielded crystals with 
non-modified DNA. Analysis of the anomalous difference density revealed however, that the 
anomalous signal was scattered and not restrained to one particular position (Figure 14).  
 
 
 
Figure 14. Brominated DNA in crystallization and structure refinement. Left panel: structures of 
bromouracil, thymine and brominated DNA used in crystallization trials. Right panel: anomalous 
difference electron density map (in purple) calculated for bromine. Two anomalous signals might result 
from binding of the DNA molecule in two opposite orientations. 
 
Based on this outcome, it was concluded that the DNA is very flexible in the crystal (anomalous 
signal is locally scattered) and hypothesized that the DNA can be bound in two 180°-opposite 
orientations (as there are two anomalous and locally scattered signals) (Figure 15). To test this 
hypothesis, a palindromic DNA was used for subsequent refinements and indeed a partial 
improvement of the positive difference density was observed. In the next attempt, a refinement 
with a PAGE-purified ds15 palindromic DNA was performed. This however did not help any 
further and it was assumed that the flexibility of the DNA was an intrinsic property of the 
tmRad50NBD-Mre11HLH-DNA crystals.  
TmRad50NBD-Mre11HLH-DNA crystals grew big and relatively thin, often as many irregular 
plates grown together. They fractured and broke easily upon touching and transfer to 
cryoprotectants. However, in most cases this fragility did not seem to affect diffraction overall; a 
bigger obstacle was twinning and multiple diffraction patterns observed in the data of a single 
crystal, coming from intergrown lattices. 
The best initial dataset recorded at SLS (2.4 Å) was indexed and integrated with XDS (Kabsch 
1993). The crystal formed in space group P2 with one molecule in the asymmetric unit and the 
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structure could be determined with molecular replacement with PHASER (McCoy et al. 2007), 
using the apo tmRad50NBD-Mre11HLH structure as a search model (PDB entry: 3QF7). Most of 
the model fit well to the calculated electron density and only a few segments of the structure had 
to be rebuilt manually. Most changes were observed at the coiled-coil domain of Rad50 and at 
the HLH motif of Mre11. After fitting in a whole B-form 15 bp DNA molecule, the model was 
subjected to limited rigid-body refinement. This re-built structure was later used as a model for 
molecular replacement of another dataset that showed clearer positive difference electron density 
for the DNA molecule (dataset collected at SLS, 2.7 Å). This time the crystal formed in P1 space 
group, with two molecules in the asymmetric unit. A number of cycles including manual model 
building and refinement in Phenix (Adams et al. 2002) led to final R-factor values of 21.54% for 
Rwork and 27.04% for Rfree. Table 18 summarizes crystallographic data and refinement statistics.  
   
Table 18. Summary of crystallographic data and refinement statistics of the tmRad50NBD-
Mre11HLH-DNA complex. Numbers in parenthesis correspond to the highest resolution shell (2.82-2.67 
Å). 
 
tmRad50NBD-Mre11HLH-DNA 
 
Data collection Refinement 
Space group P1 Resolution (Å) 47.685-2.700 
Cell dimensions  No. reflections 51439 
      a, b, c (Å) a=50.2 Rwork / Rfree 21.54 / 27.04 
 b=107.6 No. atoms  
 c=97.1      Overall 14169 
     α, β, γ (°) α=90.6      Protein 12556 
 β=98.3      DNA 1218 
 γ=89.4      AMPPNP 124 
Wavelength (Å) 1.000020      Magnesium 4 
Resolution (Å) 50.2-2.7 (2.7)      Water 267 
Rsym (%) 13.5 (68.6) B-factors (Å2)  
I/σI 9.26 (1.89)      Overall 43.37 
Completeness (%) 93.8 (80.5)      Protein 35.05 
Redundancy 3.43 (3.10)      DNA 146.11 
       AMPPNP 19.34 
  R. m. s deviations  
       Bond lengths (Å) 0.010 
       Bond angles (°) 1.405 
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4.2.2. Crystal structure of the tmRad50NBD-Mre11HLH-DNA 
The new tmRad50NBD-Mre11HLH-DNA structure retains the architecture of the previously 
reported apo structure (Lammens et al. 2011). Rad50 forms a compact dimer of overall 
dimensions of 40 x 70 x 100 Å. Roots of the coiled-coil domains protrude from the globular core 
of the protein, forming an angle of approximately 60°. Similarly to the archeal protein, NBDs of 
the Rad50 associate in the head-to-tail orientation, where lobe 1 makes contacts to lobe 2 of the 
opposing monomer (Hopfner et al. 2000). This arrangement sandwiches two AMPPNP 
molecules and two Mg2+ cations, both coordinated by a number of conserved residues (Hopfner 
et al. 2000; Lammens et al. 2011) (Figure 16). 
The Mre11-Rad50 association interface is also clearly visible in the structure and as previously 
reported, is based on hydrophobic interactions mediated by the conserved residues in the root of 
the coiled-coil domain and the HLH motif of Mre11 (Figure 15).  
The structure shows one DNA molecule bound per Rad50 dimer. In particular, the 15 bp DNA 
binds asymmetrically to only one Rad50 monomer. Inspection of the binding interface shows 
that DNA is relatively loosely associated with the protein. The binding is mediated by the 
interaction of three lysine residues with the sugar-phosphate backbone. Primarily, K115 reaches 
towards the phosphate group at a distance of 2.8 Å. The interaction is further supported by an 
analogous lysine-phosphate interaction at residues K175 and K182 within distances of 3.9 Å and 
3.5 Å, respectively. This particular arrangement shows the involvement of the coiled-coil domain 
in the DNA binding. In the structure, only one helix of the coiled-coil domain contacts the DNA. 
The structure does not imply any particular involvement of the minor/major groove of the DNA 
to have impact on the binding mode. Also, few crystal contacts at the protein-DNA interface 
explain why the DNA is flexible in the crystal, especially at the region distal from the globular 
ATPase domain.  
 
Results 
 
55 
 
 
 
 
Figure 15. Atomic models of tmRad50NBD-Mre11HLH bound to 15 bp DNA. A: front view, B: top 
view; Rad50 dimer exhibits the typical head-to-tail monomer arrangement and coordinates two AMPPNP 
molecules and two Mg2+. C: Rad50 coiled-coil domains mediate Mre11 and DNA binding. The DNA 
molecule is bound asymmetrically via three lysine residues: K115, K175 and K182.  
 
Comparison of the tmRad50NBD-Mre11HLH and tmRad50NBD-Mre11HLH -DNA structures shows 
that the DNA binding does not induce conformational changes on the Rad50 dimer or the Rad50-
Mre11 interaction interface. The new structure remains largely unaltered, with the globular part 
exhibiting identical architecture. Changes are visible at the coiled-coil domains and the HLH 
motifs. DNA-bound model is slightly less compact, with parts of the coiled-coil domains and 
HLH motifs repositioned 1.8-3.4 Å relative to the apo structure (Figure 16).  
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Figure 16. Overlay of tmRad50NBD-Mre11HLH apo and DNA-bound structures. Both structures show 
almost identical architecture. The biggest repositioning is visible at the coil-coil domains and HLH 
motifs. 
 
4.3. Characterization of the tmRad50NBD-Mre11HLH in vitro  
4.3.1. DNA binding properties of the wild-type tmRad50NBD-Mre11HLH 
As discussed in the introduction to this work, both eukaryotic MRN/MRNX and prokaryotic MR 
complexes exhibit DNA-binding activity and multiple nucleolytic activities on different DNA 
substrates. To gain insight into the DNA-binding activities of the tmRad50NBD-Mre11HLH in 
vitro, the purified and dimerized complex was assayed with different DNA species by EMSA.   
The first characteristic feature of the tmRad50NBD-Mre11HLH complex is that it exhibits enhanced 
DNA binding on longer DNA substrates (Figure 17). Clearly, a 60 bp-DNA is bound more 
efficiently than a 30 bp-DNA. In order to reach the same binding efficiency for these two DNA 
species, approximately 10 times more 30 bp-DNA would be required.  
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Figure 17. DNA-binding activity of the wild-type tmRad50NBD-Mre11HLH. The complex exhibits 
higher affinity to longer substrates as compared between 30 bp and 60 bp DNA.  
 
Current understanding of the MRN activity during DSB processing postulates that at least during 
the initial steps of HR, the complex is responsible for the recognition of the broken DNA. To test 
this hypothesis in vitro, an EMSA with intact and nicked 60 bp-DNA species was performed.  
The nicked DNA was designed in such a way that the 5’ end carried a phosphate moiety and the 
3’ end was hydroxylated. This type of a single-stranded break could be introduced in vivo during 
DNA end processing by e. g. Mre11 owing to its endonuclease activity or by other enzymes of 
the resection machinery. In this case, the nick would not only mimic a physiologically occurring 
endonucleolytic cleavage but also relax the DNA, rendering its structure more flexible. However, 
the DNA-binding efficiency is equally good on both tested substrates (Figure 18), which argues 
that the tmRad50NBD-Mre11HLH complex shows a preferential binding to modified DNA 
structures in vitro. 
 
 
 
Figure 18. DNA-binding activity of the wild-type tmRad50NBD-Mre11HLH. The complex does not 
exhibit preference towards nucleolitically modified DNA as compared between intact and nicked 60 bp 
DNA.  
 
To follow up on the idea of the DNA form affecting the DNA binding by the tmRad50NBD-
Mre11HLH in vitro, 4 different plasmid species were used in EMSA: closed nicked (circular, 
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relaxed DNA with one single-stranded break), closed nicked and religated (circular, relaxed but 
intact DNA), closed supercoiled (circular, supercoiled), and linearized. Figure 19 summarizes the 
binding activity to all of these DNA species.  
 
 
 
Figure 19. DNA-binding activity of the wild-type tmRad50NBD-Mre11HLH on plasmid substrates. A: 
closed nicked, B: closed intact, C: supercoiled, D: linearized. 
 
In this experiment no evident preference of the tmRad50NBD-Mre11HLH complex towards 
topologically changed DNA was detected. Comparison of panels A and B, as already shown on 
intact ds60 and nicked ds60 DNA (Figure 18), argues that the complex exhibits higher affinity to 
the endonucleolytically modified DNA. Furthermore, panels B and C show that the topology of 
the DNA also does not play a role in DNA binding: the tmRad50NBD-Mre11HLH complex binds 
both supercoiled and relaxed plasmid forms equally well. At the same time, results in B and D 
show that the complex does not exhibit higher affinity to DNA with exposed ends, since no 
difference in DNA binding activity is visible between closed and linearized plasmid species.  
4.3.2. Model of DNA binding and DNA-binding properties of the tmRad50NBD-
Mre11HLH point mutants 
Since the DNA visible in the structure does not clearly point out towards the location of the 
Mre11 active site in the full-length complex (Figure 38, Discussion), it is still not clear how it 
could be processed by Mre11 in vivo. For this reason, in order to shed more light onto DNA-
binding properties of the protein in vitro, a number of point mutations were introduced into the 
tmRad50 gene (Figure 20).  
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Figure 20. Surface representation of the tmRad50NBD-Mre11HLH complex (grey) with DNA helix 
(wheat, stick representation). Top panel: front view. Residues chosen for site-mutagenesis located on 
the opposite monomers are marked in purple and pink, respectively. Residues S768 and E798 are buried 
and therefore not visible in the picture.  
 
The three lysine residues revealed in the structure to form protein-DNA contacts (K115, K175, 
K182) were the first choice and at all these positions the lysine was substituted by glutamic acid.  
In the light of previous studies, it was suggested that the DNA-binding interface might be located 
on the surface formed in the Rad50 dimer between the coiled-coils domains. According to the 
calculated surface potential of the tmRad50NBD-Mre11HLH complex, this particular interface 
encompasses a positively charged patch that could mediate DNA binding in vivo (Mockel et al. 
2012) (Figure 21). In order to determine if some conserved residues belonging to this putative 
binding groove would affect DNA binding in vitro, mutations R94E, K95E and R765E were 
introduced.  
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Figure 21. Representation of the surface charge of the tmRad50NBD-Mre11HLH (PDB entry: 3QF7). 
Interface located at the Rad50NDB dimer between coiled-coil domains is positively charged and could be 
involved in DNA binding.  
 
Assuming that the DNA-binding interface would involve K115 and the positive residues of the 
putative binding groove, other positively charged residues at the lateral side of the globular 
ATPase domain could also play a role in the DNA binding. To test this hypothesis, several 
conserved lysines (K99, K108, K109) were mutated to glutamic acid.  
DNA could also bind from the K115 residue along the surface of the globular ATPase domain 
towards the Mre11 active site. Therefore, a number of conserved residues localized centrally and 
at the base of the ATPase domain were introduced: R2Q, R5Q, R9E and N10D. These residues 
were also described as Rad50S (separation of function) mutants in S. cerevisiae (Alani, Padmore, 
and Kleckner 1990), exhibiting chronic ATM-checkpoint activation.  
Two conserved residues: S768 and E798 involved in ATP binding and hydrolysis, respectively, 
were mutated to serve as an internal control. The signature motif S768R mutant was previously 
shown to be deficient in ATP binding and therefore Rad50 dimerization, whereas Walker B 
E798Q mutant should similarly to Walker A mutant impair ATP hydrolysis with no effect on 
ATP binding and Rad50 dimerization (Moncalian et al. 2004; Bhaskara et al. 2007).  
All residues mutated for the in vitro DNA-binding analysis were checked for conservation in 
eukaryotes (in particular in S. cerevisiae), so that subsequent in vivo analysis could be performed 
to complement the study. The coiled-coil residues K175 and K182 showed only partial 
conservation. However, both of these residues were still tested in DNA-binding assay in vitro on 
the assumption that the DNA-coiled-coil association is conserved but guided by other residues in 
other species.  
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Preparation and dimerization of tmRad50NBD-Mre11HLH point mutants 
Point mutations in the tmRad50NBD-Mre11HLH construct were introduced by site-directed 
mutagenesis. Mutants were expressed and purified according to the protocol used in the 
preparation of the wild-type protein. All point mutants were expressed equally well as the wild-
type protein and did not show any enhanced instability. In order to confirm that the introduction 
of mutations would not impair dimer formation of the Rad50 monomers, AMPPNP was added to 
protein preparation and dimerization was monitored in gel filtration, as described for the wild-
type protein. The majority of the mutants showed the same dimerization efficiency as the wild-
type protein, including the speed rate of the dimer formation. This was also true for 
R94E+K115E and K95E+K115E double mutants.  
Different behaviour was observed for mutants R765E, S768R and E798Q. As expected, 
signature motif mutant (S768R) remained in the monomeric form. This particular mutation was 
showed before to impair ATP binding and dimer formation. Walker D mutant (E798Q) 
dimerized at a slower rate, with the final dimerization efficiency of approximately 75%. In case 
of this mutant, ATP-binding and subsequent dimer formation are expected. The mutant should 
however exhibit no ATP hydrolysis. R765E mutant showed also a slightly slower dimerization 
rate, but the final efficiency reached the maximum of approximately 85%, comparable with the 
wt protein (Figure 22).  
 
 
 
Figure 22. AMPPNP-induced dimerization of selected tmRad50NBD-Mre11HLH mutants. Signature 
motif mutant S768R remains in a monomeric form. Walker B mutant E798Q shows slower dimerization 
compared to the wild-type protein, with the maximum efficiency of approximately 75%. R765E mutant 
also dimerizes at a slower rate but reaches 85% dimerization efficiency, comparable to the wild-type 
protein. 
 
DNA binding properties of the tmRad50NBD-Mre11HLH point mutants 
DNA-binding activity of tmRad50NBD-Mre11HLH point mutants was analyzed and compared to 
the wild-type protein (Figure 23). In this assay, binding of a circular nicked plasmid was tested. 
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The wild-type protein, as already shown before, exhibited high binding affinity already in the 
nanomolar range. Clearly, among the structure-based mutants, the K115 residue showed the 
strongest effect on the DNA binding. In particular, K115E mutant was unable to bind DNA; an 
insignificant shift could only be observed at extreme protein molar excess. Two other mutants 
based on the protein-DNA contacts visible in the crystal structure, K172E and K185E, showed 
only partial inhibition of the DNA binding, much less pronounced than K115E.  
In case of the residues involved in the proposed DNA-binding groove (R94, K95 and R765), 
R94E and K95E mutants exhibited a dramatic decrease of the DNA-binding activity, comparable 
with the K115E mutant. R765E mutant also strongly impaired DNA binding but not as severely 
as the R94E, K95E and K115E mutants. Double-mutants R94E+K115E and K95E+K115E 
caused a strong inhibition of DNA binding, comparable to the K115E single mutant. 
Conserved residues (K99, K108 and K109), that were hypothesized to play a role in forming the 
DNA-binding path between K115 and the putative binding groove, also strongly affected DNA 
binding. In particular, K99E mutant showed significantly low DNA-binding activity.  
Rad50S mutants (R2Q, R5Q, R9E and N10D) had on the other hand a rather mild effect, with the 
R9E mutant showing the strongest inhibition of the DNA binding, comparable with the structure-
based K182E mutant.  
Mutations of residues involved in ATP binding and hydrolysis (signature motif mutant S768R 
and Walker B mutant E798Q) also had a pronounced effect on DNA binding. S768R mutant 
strongly impaired the binding in a manner comparable with the mutants K99E and R765E. 
S768R still exhibited a higher affinity towards DNA than a monomeric tmRad50NBD-Mre11HLH 
assayed in the absence of AMPPNP. This result confirmed previously published observations 
that the DNA binding also partially stimulates dimerization, but the full dimer formation is 
dependent on ATP and Mg2+ (Lammens et al. 2011). E798Q bound DNA readily in the 
nanomolar range like the wild-type protein but the binding was less efficient.  
In summary, most of the tested mutations disturbed DNA-binding activity of the tmRad50NBD-
Mre11HLH dimeric complex and the strength of this effect varied among distinct mutants.  
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Figure 23. Comparison of the DNA-binding activity of the wild-type (wt) and mutant tmRad50NBD-
Mre11HLH complexes. Details in text. 
 
4.4. Structure-based characterization of Rad50 point mutations in S. cerevisiae 
The structure of the tmRad50NBD-Mre11HLH-DNA together with the in vitro analysis of DNA 
binding does not evidently explain how the complex would recognize and bind DNA in the 
physiological context of chromatin and two free DNA ends at a DSB site. In order to verify the 
significance of the features in DNA-protein interface revealed by the structure together with 
other Rad50 residues tested for the involvement in DNA binding, a number of mutations were 
introduced into Rad50 gene and tested in vivo in S. cerevisiae. Conserved residues that showed 
strongest DNA-binding inhibition in vitro were selected for this assay. Figure 24 shows the 
sequence alignment between bacterial (T. maritima), human (H. sapiens) and yeast (S. cerevisiae 
and S. pombe) Rad50 orthologues. Almost all chosen residues showed conservation in these 
species, pointing towards their potential importance across all domains of life.  
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Figure 24. Sequence conservation of N- and C-terminal segments of Rad50 orthologues from T. 
maritima, S. cerevisiae, S. pombe and H. sapiens. Walker A, Walker B and signature motif are marked 
in purple. Orange dots mark residues mutated only in tmRad50NBD, red dot marks residues mutated in 
tmRad50 and scRad50.  
 
4.4.1. Response to DNA damage 
In order to compare the effect of Rad50 point mutations in vivo, a complementation assay with 
the ∆rad50 S. cerevisiae strain was employed. The knock-out strain is viable in complete 
medium (YPD), although it grows slower compared to the wild-type strain.  
One way to determine whether residues found to be critical for DNA binding in vitro would also 
mediate DNA recognition in vivo is to monitor the survival of Rad50 mutants on DNA-damaging 
agents in comparison to the wild-type cells. To this end, S. cerevisiae W303-1a wild-type and 
W303-1a ∆rad50 strains were transformed with an empty pRS313 vector (centromeric plasmid 
with His marker). W303-1a ∆rad50 was also transformed with pRS313 carrying a wild-type 
scRad50 allele. Growth of these transformants was monitored on the synthetic medium without 
histidine (control) and on the medium containing camptothecin (CPT), methyl methanesulfonate 
(MMS) and hydroxyurea (HU) as DNA-damaging agents (Figure 26). ∆rad50 retained viability 
on the complete medium but its growth was retarded. On the contrary, supplementation of the 
medium with DNA-damaging agents severely impaired ∆rad50 survival, confirming the 
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requirement of the functional MRX complex in DSB repair in vivo. Complementation of the 
∆rad50 strain with a wild-type allele of Rad50 restored the phenotype to the level of wild-type 
strain. This result also indirectly confirmed that the scRad50 gene introduced on a plasmid was 
properly expressed and retained its function in vivo (Figure 25).  
 
 
 
Figure 25. Growth behaviour of S. cerevisiae transformants on regular medium SDC(-His) and 
medium supplemented with DNA-damaging agents. ∆rad50 strain transformed with empty pRS313 
plasmid does not survive genotoxic stress (∆rad50) caused by captothecin (CPT), methyl 
methanesulfonate (MMS) or hydroxyurea (HU). Transformation of the ∆rad50 strain with the wild-type 
allele of scRad50 (∆rad50+Rad50wt) rescues the phenotype to the wild-type level (wt). 
 
Based on previous studies (D'Amours and Jackson 2001), observed phenotypes were expected 
and allowed to employ this assay for monitoring the DNA damage response in S. cerevisiae 
Rad50 mutants. To this end, the ∆rad50 strain was transformed with the pRS313 constructs 
carrying mutated scRad50 alleles and the survival of the transformants was monitored as 
described before on media supplemented with DNA-damaging agents.  
Interestingly, only several of tested mutations showed an altered phenotype compared to ∆rad50 
and ∆rad50+wtRad50 transformants (Figure 26). Clear phenotypic effect was observed for the 
mutant R1201E and as expected for the signature motif mutant S1205R and Walker B mutant 
E1235Q. These mutants exhibited partially retarded growth already on complete medium, 
resembling the ∆rad50 strain. In the view of the DNA damage response, R1201E, S1205S and 
E1235Q were again phenotypically similar to the ∆rad50 strain, showing strongly impaired 
growth on DNA-damaging agents. Out of the three used genotoxins, CPT induced the strongest 
phenotype, rendering the transformants almost inviable. MMS had a more pronounced effect on 
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the R1201E mutant than on S1205S and E1235Q mutants, but all these mutants responded better 
to MMS-induced DNA damage than the ∆rad50 strain. 
Response to HU affected the signature motif S1205R mutant in the most severe manner. Under 
these conditions, S1205R was phenotypically identical with the ∆rad50 strain. R1201E and 
E1235Q mutants showed better survival on HU-supplemented medium than S1205S, but their 
growth was still severely impaired, when compared to the wild-type and rescued ∆rad50 
transformants.  
A weak but still persistent effect on growth and DNA damage response was observed for the 
double-mutant K103E+R131E. This mutant exhibited slight growth retardation already on the 
complete medium. This behaviour was manifested also on the CPT-supplemented medium, and 
to a lesser degree on the HU-supplemented medium.  
The rest of the tested mutations did not induce phenotypic effect on growth and response to DNA 
damage in vivo. K103E, K104E, R131E and K104E+R131E mutants, analogous to the DNA-
binding deficient mutants of tmRad50NBD-Mre11HLH (R94E, K95E, K115E, K95E+K115E), 
showed unaffected growth on SDC(-His) medium and  normal DNA damage response, 
comparable to ∆rad50+Rad50. Similarly, the structure-based mutant N190D (tmRad50 K175E 
that showed partially impaired DNA binding in vitro), did not show any growth retardation or 
impair in DNA damage response in S. cerevisiae.  
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Figure 26. Growth behaviour of S. cerevisiae transformants on regular medium SDC(-His) and 
medium supplemented with DNA damaging agents. Transformation of the ∆rad50 strain with most of 
the mutated alleles of scRad50 rescues the phenotype to the wild-type level (∆rad50+ Rad50wt). R1201E, 
S1205R and E1235Q show strongly impaired DNA damage response, comparable to ∆rad50 strain. 
K103E+R131E double mutant shows partially impaired DNA damage response. 
 
In order to check if the observed phenotypes did not arise as the cause of a decreased cellular 
level of Rad50, the expression level of Rad50 allele was monitored by Western blot on yeast 
whole-cell lysates. As shown in (Figure 27), all transformants expressed Rad50 normally. 
 
 
 
Figure 27. Rad50 expression level in S. cerevisiae transformants. All of the mutated Rad50 alleles are 
well expressed, with the expression level comparable to the wild-type and rescued ∆rad50 strains. 
 
Results 
 
68 
 
4.4.2. End-joining activity 
The significance of different Rad50 motifs was further investigated in vivo in an end-joining 
analysis. Interestingly, this experiment revealed that in addition to residues determined to be 
crucial for DNA-damage response (R1201E, S1205R and E1235Q), mutants K103E and K104E 
exhibited partial decrease in end-joining efficiency with a linearized plasmid (Figure 28). 
Moreover, this effect was enhanced in K103E+R131E, but not K104E+R131E double-mutant, 
although the R131E mutant remained unaffected. End-joining activity was also severely affected 
in the coiled-coil mutant N190D, although this mutation did not influence response to DNA 
damage. 
 
 
 
Figure 28. End-joining activity of S. cerevisiae Rad50 mutants. All residues determined to be 
important for DNA-damage response are also significant for end-joining repair (mutants R1201, S1205R, 
E1235Q, K103E+R131E). In addition, coiled-coil mutant N190D exhibits a strong defect whereas 
mutants K103E and K104E a partial defect in end-joining. 
 
4.4.3. Telomere maintenance 
Yeast telomeres consist of poly(GT) repeats (300 bp), located downstream from the conserved X 
or XY’ elements. Y’ element includes a conserved XhoI restriction site and the genomic DNA 
isolated from wild-type S. cerevisiae strains treated with this restrictase generates a 1-1.3 kbp 
fragment containing the poly(GT) repeat. The repeat can be visualized by Southern blot, using a 
radioactively labelled hybridization probe that anneals to the repeat. This particular assay was 
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employed to determine if the Rad50 mutations tested for DNA damage response would show an 
altered phenotype in maintaining telomeres when compared to the wild-type and ∆rad50 strains. 
As depicted in Figure 29, the ∆rad50 strain had significantly shorter telomeres but 
complementation with the wild-type scRad50 allele restored its phenotype to the wild-type level. 
K103E and K104E mutants showed a partial impair of telomere maintenance. Interestingly, this 
effect was enhanced in the K103E+R131E double mutant and comparable to the ∆rad50 strain, 
although the single R131E mutant exhibited the wild-type phenotype. Signature motif mutant 
S1205R was strongly defective in telomere maintenance, confirming again the significance of 
the Rad50 dimerization in distinct functions of the MRN complex. The same phenotype was 
observed for the R1201E mutant. Notably, Walker B mutant E1235Q showed an unaltered 
phenotype, which argues against the role of the ATP hydrolysis in the MRN function at 
telomeres.   
Interestingly, it is possible that the coiled-coil mutant N190D formed longer telomeres compared 
to the wild-type strain. In order to verify this, telomere maintenance in this strain would have to 
be thoroughly investigated over the time span of more generations. 
 
 
 
Figure 29. Analysis of telomere maintenance in the wild-type, ∆rad50 and rescued ∆rad50 strains. 
Strongest telomere shortening, comparable to ∆rad50 strain is exhibited by single mutants R1201E, 
S1205R and double mutant K103E+R131E. Mild effect is observed for K103E and K104E mutants. 
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4.5. Establishment of the hMRN-induced ATM activation in Xenopus laevis interphase egg 
extract 
Interphase egg extract from X. laevis can recapitulate a number of cellular events, including 
replication, DNA repair, checkpoint control and chromatin remodelling and has been therefore 
widely used to study molecular principles of these processes. In particular, DNA-induced ATM 
signalling can be reconstituted in interphase extracts depleted of the endogenous xlMRN 
complex and supplemented with the wild-type recombinant human complex (Costanzo et al. 
2001). This experimental set-up could be employed to monitor ATM signalling in the presence 
of the mutant hMRN complex and determine the link between structural features of the complex 
and its function as the signalling mediator. 
4.5.1. Preparation of the recombinant hMRN 
Expression and purification of the full-length recombinant human MRN complex was first 
reported in 1999 (Paull and Gellert 1999). This protocol, with minor modifications, was used to 
prepare the hMRN complex in this work. In contrast to the original protocol, the complex carried 
only one polyhistidine tag at the C-terminus of Rad50. It was shown though, that this 
modification did not affect complex formation and purification. Also, hMRN was expressed in 
HighFive insect cells for 72 hours, rather than in Sf9 insect cells for 48 hours and the cells were 
infected with a single baculovirus carrying all three genes of the MRN complex. In the original 
work cells were co-infected with three separate baculoviruses. Again, it was shown that this 
modification did not alter the expression level or the behaviour of the complex during 
purification.  
The complex was first purified on NiNTA resin. High DNA contamination could be easily 
removed during the ion exchange step and finally the complex was subjected to gel filtration on 
Superose 6 column. As shown in the gel filtration elution profile (Figure 30), the complex 
formed a number of species. This result was contradictory to the previously published study 
where the authors claimed to obtain a complex of approximately 1.2 MDa (Paull and Gellert 
1999). Furthermore, the stoichiometry of the complex was clearly disturbed, with Nbs1 being 
underexpressed relative to Mre11 and Rad50 (Figure 30).  
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Figure 30. Elution profile of the recombinant human full-length MRN complex in gel filtration. The 
complex forms several oligomeric species. Nbs1 is at substoichiometric level. 
 
Attempts to obtain a more homogenous sample with less impurities and an elevated Nbs1 level 
failed. These included expression of the complex in HighFive cells co-infected with separate 
Mre11/Rad50- and Nbs1-baculoviruses at a high excess of the latter one. Also, placing the 
polyhistidine tag at the C-terminus of Nbs1 instead of Rad50 or Mre11 did not improve the 
purity and stoichiometry of the complex.  
 
4.5.2. Interphase X. laevis egg extracts 
X. laevis egg extract suitable for studies of mitotic DSBs should be blocked at the early stage of 
interphase, preferably in phase G1. Such extracts are still able to proceed to S- and G2-phases of 
the cell cycle. In order to test whether extracts were indeed halted in G1 phase, demembrated 
sperm nuclei were introduced to the extract. Responsive extracts (i. e. G1-phase extracts of good 
quality) should in this case recapitulate replication. As shown in Figure 31, extract prepared in 
this work were fully capable of restoring replication on sperm DNA, as monitored by 
incorporation of the Cy3-labelled dCTP in the newly synthesized DNA. 
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Figure 31. Replication of demembrated sperm nuclei in X. laevis egg extract. Chromatin in sperm 
nuclei changes from compact (A) towards a more loose and relaxed form (B and C). Incorporation of the 
Cy3-dCTP into the newly synthesized DNA is well visible after 60 min upon the nuclei addition.  
 
4.5.3. DNA-induced ATM activation in interphase X. laevis egg extracts 
In order to monitor checkpoint signalling elicited by hMRN mutants, interphase extract from 
Xenopus laevis unfertilized eggs was used. In the assay, the extract was first depleted of the 
endogenous cellular MRN complex with the anti-xlMre11 polyclonal serum. The efficiency of 
the immunodepletion was very high, as monitored by Western blot analysis (Figure 32).  
 
 
 
Figure 32. Immunodepletion of the endogenous MRN complex from X. laevis egg extract. 
Immunodepletion efficiency with polyclonal anti-xlMre11 serum is very high as monitored  by a Western 
blot analysis performed against xlMre11. ∆: depleted extract, M: mock extract. 
 
DNA damage was mimicked by the introduction of exogenous blunt-ended DNA to the extract 
and the signalling response was monitored by the appearance of the phopshorylated species of 
ATM (autophosphorylation site S1981). Optimization of this experimental setup included type of 
DNA to induce the response (poly(A)/poly(T) duplex, phage λ DNA-BstEII digest, 200 bp blunt-
ended PCR product), DNA concentration in the extract, reaction time and reaction temperature. 
In established conditions, a clear phosphorylation of the ATM was detected in mock extract, 
whereas no ATM phosphorylation could be visible in the xlMRN-depleted extract (Figure 33). 
The response was very fast, with a partial ATM-phosphorylation already detectable after 2 
minutes upon stimulation with DNA.  
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Figure 33. ATM phosphorylation in X. laevis egg extract. DNA-induced ATM phosphorylation is 
visible only in mock extract (M), but not in xlMRN-immunodepleted extract (∆). ATM is also not 
phosphorylated in extract not stimulated with DNA.  
 
4.6. Rescue of ATM activation by the hMRN complex 
ATM signalling in Mre11-depleted X. laevis egg extract was shown before to be recapitulated by 
addition of recombinant hMRN (Costanzo et al. 2001). In order to see whether the hMRN 
complex prepared in this work would also restore ATM phophorylation upon DNA damage, the 
optimized assay (paragraph 4.4.3.) was employed. It was expected that supplementation of the 
xlMRN-depleted extract with the hMRN complex would result in ATM phosphorylation upon 
addition of DNA. Unfortunately, this result was never observed in the extract (Figure 34).  
 
 
 
 
Figure 34. Rescue experiment in X. laevis egg extract. Recombinant hMRN does not restore DNA-
induced ATM phosphorylation in xlMRN-immunodepleted egg extract (∆) even after 60 min from 
reaction start. At the same time, hMRN storage buffer does not affect ATP phosphorylation in the mock 
extract (M).  
 
To rule out that the activity of the hMRN is affected by its oligomerization state, distinct species 
of the complex formed in gel filtration were tested separately. Moreover, attempts were made to 
enrich the sample with the signalling subunit Nbs1. However, they turned out to be unsuccessful.  
As the extract is extremely sensitive to dilution and addition of certain buffers, the hMRN 
complex was dialysed to buffer containing 10 mM Hepes-KOH pH 7.5, 100mM KCl and 1 mM 
DTT (V. Costanzo, personal communication) or 10 mM Hepes-KOH pH 7.7, 50 mM KCl, 2.5 
mM MgCl2, 250 mM sucrose (Dupre, Boyer-Chatenet, and Gautier 2006) prior to rescue 
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experiments. These buffer conditions are believed to be more suitable for the work with the X. 
laevis egg extracts as they do not affect the behaviour of the extract if added in small amounts 
(V. Constanzo, J. Gautier, personal communication). Again, these attempts also did not improve 
the DNA damage response in the depleted extract and eventually no rescue of ATM signalling 
was observed. For this reason, further experiments including mutants of the hMRN complex 
could not be performed.  
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5. Discussion 
Double-strand breaks and their repair 
Double-strand breaks are one of the most deleterious DNA lesions and pose a severe threat to 
genome stability. DSBs appear as a result of DNA exposure to a number of damaging agents of 
both physical and chemical nature. The most harmful factors responsible for the DSB formation 
are ionizing radiation, reactive oxygen species and genotoxic agents. Moreover, factors that 
interfere with progression of replication often result in stalling and subsequent collapse of the 
replication fork, exposing “naked” DNA ends and eliciting a response similar to DSBs. 
Many of the DNA modifying or damaging agents lead to damage formation of nature different to 
DSBs. These lesions are recognized by distinct repair systems but, unless repaired, they are often 
transformed into DSBs. Furthermore, certain cellular events include generation of programmed 
DSBs. Such physiological breaks are formed in a tightly regulated manner and are crucial to 
crossing-over events during meiosis, mating-type switching in S. cerevisiae or V(D)J 
recombination fundamental to the development of adaptive immune system in vertebrates.  
Both spontaneous and programmed DSBs pose a threat to genome stability and their 
accumulation can lead to severe genetic disorders including cancer. A single DSB is sufficient to 
induce checkpoint activation, assuring that the cell cycle halts in order to give the repair 
machinery time to respond to the lesion. However, if this repair mechanism fails, continuous 
DSB signalling promotes shutdown of the cellular metabolism followed by programmed cell 
death (Friedberg 2003).   
There are two alternative DSB repair pathway: homologous recombination and non-homologous 
end joining. The HR system is considered accurate and mostly error-free and bases on an 
extensive resection of the DNA ends followed by a replication-governed repair and use of 
homology segments available on the lesion-free sister chromatid. On the other hand, the NHEJ 
system is characterized by a limited DNA end resection followed by a direct end joining, usually 
not accompanied by a large-scale replication-governed repair. For this reason, NHEJ is 
considered a more error-prone repair pathway, leading to possible deletions (Hartlerode and 
Scully 2009).  
HR and NHEJ systems are employed by yeast and higher eukaryotes with different preference. 
Yeast repair their DSBs predominantly via HR, whereas mammalian genomes are protected 
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mostly by NHEJ-associated factors. The reason for this discrepancy and the principles governing 
the repair pathway choice are so far not entirely clear. A number of recently published studies 
reports many of the DSBR and cell cycle control factors to play a role in balancing HR/NHEJ 
pathways (Chapman, Taylor, and Boulton 2012). 
 
Mre11-Rad50-Nbs1 complex: facts and open questions 
Protein landscape of the DSB repair and signalling is very complex but largely conserved 
throughout the domains of life. One of the key players in this plethora of factors is the Mre11-
Rad50-Nbs1 (Xrs2) complex, with the highly conserved Mre11-Rad50 enzymatic core. MRN/X 
plays a multifaceted role in the repair of mitotic breaks but is also indispensible for other cellular 
events (Figure 35). These include telomere maintenance, V(D)J recombination, repair of meiotic 
DSBs and DNA damage induced checkpoint activation. More recently, new functions of the 
MRN complex in the progression of mitosis and innate immunity response to viral infection were 
reported (Kondo et al. 2013; Rozier et al. 2013). The complex is required for both DSB repair 
pathways but its function has been best described for homologous recombination. In the course 
of HR, the MRN is believed to recognize and bind to the damage site, form a structural scaffold 
for other repair proteins and interact with ATM checkpoint kinase, mediating the damage event 
to the cell cycle control machinery. The complex plays an important mechanistic role at the 
damage site: it is able to tether DNA ends together and participate in bridging distal homologous 
DNA segments. Due to its enzymatic activities, it also takes part in early resection events 
(Stracker and Petrini 2011).  
 
 
Figure 35. Model of the MRN complex and its implications for MRN functions. 
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Extensive studies of the diverse roles of the MRN complex have greatly contributed to the 
current understanding of the functional features governing its function in distinct cellular 
processes. However, many fundamental characteristics still await clarification. One of the most 
fundamental questions was to mechanistically understand how the complex senses DNA breaks. 
It was proposed that the DNA-binding interface is located on the enzymatic core of the complex, 
i. e. Rad50 ATPase and Mre11 nuclease domains. Archeal Mre11 structure bound to DNA gave 
first insight into the mechanism of DNA binding (Williams et al. 2009) but became later difficult 
to interpret in the context of the full-length Mre11-Rad50 complex. Namely, the initially 
determined DNA-binding pocket at the Mre11 active site was later found to be closed off by the 
Rad50 ATPase domain (Figure 7, Introduction) (Lim et al. 2011; Mockel et al. 2012).  
To address molecular principles of the DNA recognition, the catalytic domain of the bacterial 
orthologue of Rad50 together with a short interacting motif of Mre11 was crystallized in 
complex with 15 bp DNA. In the attempt of verifying structural information and understanding 
the significance of structural features of the Rad50-DNA assembly, extensive mutagenesis 
studies were performed both in vitro in DNA-binding assays and in vivo in DNA damage 
response in S. cerevisiae.  
 
Towards the structure of Rad50-DNA assembly 
The Mre11-Rad50 subcomplex exhibits a high degree of sequence and structural conservation 
throughout species. Preparation of the recombinant eukaryotic Mre11-Rad50-Nbs1 complex, 
including its individual subunits and subcomplexes, suitable for X-ray diffraction studies posed a 
lot of difficulty. Attempts of expressing the MRN complex, both full-length and truncated 
constructs, from four different eukaryotic species (S. pombe, D. melanogaster, H. sapiens, E. 
cuniculi) were mostly unsuccessful (data not shown). Recombinant expression was performed in 
E. coli and in baculovirus-infected insect cells and in the end only the full-length hMRN 
complex could be purified from insect cells. The quality of this protein sample was however not 
high enough to pursue further structural studies. For this reason, a bacterial orthologue of Rad50 
from T. maritima was chosen to be used in the structural studies presented in this work. In fact, 
archeal and bacterial orthologues of both Mre11 and Rad50 have been widely employed before 
in structural investigations of the MR complex and largely contributed to the understanding of 
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the subunit arrangement in the complex and the structural-functional relation between its 
enzymatic activities.  
Since the MR complex from T. maritima has been such a potent tool in recent studies, tmRad50 
catalytic head composed of the nucleotide-binding domain (tmRad50NBD) together with a short 
interacting helix-loop-helix motif of Mre11 (tmMre11HLH) was chosen for crystallization with 
DNA. T. maritima belongs to hyperthermophilic organisms, thereby being an attractive species 
for structural studies. The proteome of thermophilic organisms exhibits high stability and 
compactness, both being of preferential characteristics in the choice for crystallization 
experiments. Moreover, optimal living temperature of T. maritima ranges between 55-90°C. Due 
to this fact, the E. coli cell lysate containing recombinant tmRad50NBD-Mre11HLH complex could 
be precleared by incubation at 60°C. This additional purification step can often be taken 
advantage of while working with recombinant proteins from thermophilic species. 
The minimal tmRad50NBD-Mre11HLH protein construct suitable for bicistronic expression was 
readily crystallized before and therefore chosen as a minimal subcomplex for further studies of 
the DNA recognition. The construct lacked the long coiled-coil domain. This large helical 
segment of Rad50 is characterized by high intrinsic flexibility and is therefore not suitable for 
crystallization purposes. Also, the Mre11 construct included only the C-terminal helix-loop-helix 
motif that was identified as the minimal part to interact with the root of the Rad50 coiled-coil 
domain. Due to the fact that previous attempts of crystallizing tmRad50NBD together with the 
full-length Mre11 and DNA were unsuccessful (C. Möckel, personal communication), the N-
terminal nuclease and capping domains were excluded from the expression construct. 
As reported before, the minimal tmRad50NBD-Mre11HLH protein construct was highly stable 
during purification procedure and the final yield, purity and homogeneity of the protein facilitate 
crystallization trials. The protein, although eluting in gel filtration as a monomeric species (i. e. 
comprising only one Rad50 molecule with one helix-loop-helix motif of Mre11), efficiently 
formed a stable dimer upon AMPPNP addition.  
The tmRad50NBD-Mre11HLH complex, together with DNA and AMPPNP, was subjected to 
extensive crystallization trials. DNA of different length was tested and the sample was screened 
against various conditions. Several conditions yielded crystals but the processing of diffraction 
data revealed that most of them contained only tmRad50NBD-Mre11HLH dimer. Only one of the 
initial conditions turned out to yield DNA-bound tmRad50NBD-Mre11HLH complex.  
Discussion 
 
79 
 
DNA-containing crystals that gave diffraction data suitable for the structure determination 
contained a 15 bp DNA duplex. At the stage of initial data analysis, the difference density 
coming from the DNA molecule was not very clear and a number of attempts was undertaken to 
improve DNA binding in the crystal. Screening DNA of varying lengths and “saturating” the 
protein-DNA crystallization solution with DNA did not bring clear improvement and at that 
stage it was already postulated that the DNA does not form very tight contacts to the protein. In 
order to recognize and assign the DNA registry, further refinements included co-crystallization 
with brominated DNA. The bromine atom provided possibility of calculating the anomalous 
electron density. Although this attempt did allow for assigning the DNA sequence, the locally 
scattered anomalous signal proved again that the DNA molecule was a highly flexible element in 
the structure. Moreover, observation of clear two anomalous signals calculated for a molecule 
containing one bromine atom only suggested that the DNA molecule could orient in two opposite 
directions within protein molecules of the same crystal. This would then mean that the electron 
difference density represented an average of the two possible DNA positions in the crystal and 
be therefore poor in details. In order to verify this possibility, palindromic DNA was used and 
indeed this approach significantly improved data quality.    
 
Rad50-DNA structure 
In the last years, a number of atomic models of prokaryotic MR orthologues have been 
published, including the tmRad50NBD-Mre11HLH (apo) structure (Lammens et al. 2011). The new 
tmRad50NBD-Mre11HLH-DNA model largely depicts all the structural features reported for the 
apo structure. The Rad50 NBDs arrangement is preserved, with the classical head-to-tail dimer 
interface, encompassing bipartite ATPase domains. Similarly, AMPPNP and Mg2+ binding is 
again clearly visible in the structure and maintained by the already described conserved motifs: 
Walker A and B motifs together with the signature motif. Also, the Rad50-Mre11 interaction 
interface exhibits no changes.  
Most notable differences between the DNA-bound and the apo structures are visible at the 
coiled-coil domain. Within this region a shift of 1.8-3.8 Å is observed. These conformational 
changes can be induced by the DNA-binding. However, such alterations might also arise due to 
the molecule arrangement in the crystal, especially that they appear at the part of the protein 
proved to be prone to higher flexibility (coiled-coils) rather than more compact globular 
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enzymatic core of the complex. Furthermore, the change of conformation can result from DNA 
binding and be further intensified by the position, orientation and intramolecular contact within 
the crystal structure. 
The new tmRad50NBD-Mre11HLH-DNA structure may have trapped a very initial state of the 
Rad50-DNA assembly. A tempting hypothesis would be that once the DNA is bound, Rad50 
hydrolyses ATP and undergoes a conformational rearrangement that in turn affects DNA 
location on the complex and/or DNA structure. This ATP-induced DNA relocation could deliver 
DNA at the nuclease site of the Mre11, influencing also the cross-talk between enzymatic 
processing of the break and Nbs1-mediated signalling.  
 
DNA recognition 
The DNA-bound structure shows only one DNA molecule associated with a Rad50 dimer. 
Binding is asymmetrical and coordinated by only one Rad50 monomer. Moreover, the DNA 
shows a loose association with the protein. Three residues on the protein side could be clearly 
identified to mediate the DNA binding (K115, K175 and K182). These lysines contact phosphate 
moieties of the sugar-phosphate backbone (Figure 15, Results). Other than that, the model gives 
no evidence of other type of the DNA-protein interaction, such as minor/major groove 
recognition or end recognition. The binding is sequence independent which can be inferred from 
the fact that the crystals were formed with almost all types of tested DNA. In particular, 15 bp 
DNA with 1 nt overhang had an entirely different sequence from the palindromic 15 bp duplex 
and yet both crystals yielded comparable electron densities for the DNA. Sequence-independent 
binding is expected since a DSB can occur at any locus and the repair machinery should be 
equally efficient at the whole DNA span, irrespective of the sequence.  
The DNA binding is coordinated in the structure also via the coiled-coil residues. Both of them 
(K175 and K182) are semi-conserved in higher eukaryotes. It is however possible that the coiled-
coils-supported DNA binding occur in all species, but is coordinated by different positively 
charged residues, depending on the species. The structure shows that only one out of the two 
helices of the coiled-coil domain supports DNA binding. In vivo, binding could be mediated by 
more distal segments of the coiled-coil domain involving both helices. Such hypothesis would 
support the already observed significance of the coiled-coil domain in many MRX/MRN 
functions (Hohl et al. 2011). This report clearly shows that the full-length coiled-coil domain is 
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absolutely indispensable for preserving healthy cellular physiology, including telomere 
maintenance, repair of meiotic breaks and homologous recombination. It has been proposed that 
the flexible coiled-coil domain might participate in the proper arrangement of the ATPase 
domains of Rad50 and that even subtle alterations at distal segments of the coiled-coils could 
affect the catalytic activity of the whole complex. Coiled-coils-coordinated DNA recognition and 
binding would nicely complement this hypothesis.   
Although the electron density accounted for the DNA molecule was not very clear, it is most 
likely an undistorted B-form DNA. There is no evident evidence that Rad50 elicited any changes 
in DNA topology: no DNA melting or bending can be deduced based on the electron density. 
However, it still cannot be excluded that such activity on DNA is indeed performed in vivo. It 
would likely be linked to ATP hydrolysis and in that case, a number of atomic models of the 
intermediate states of the Mre11-Rad50-DNA assembly should be investigated in order to gain 
insight into mechanistic details of this process.  
Although the atomic model of DNA-bound tmRad50NBD-Mre11HLH is not very intuitive, 
mutational analysis supported the significance of the DNA binding residues revealed by the 
structure as assayed in vitro in DNA-binding experiments. Particularly, the K115 residue turned 
out to play a fundamental role in this activity. Impair of the DNA binding was also visible to a 
degree for the coiled-coil mutants K175E and K182E. Their effect was not as strong as observed 
for the K115E mutant, but as deduced from the poor electron density for the DNA in this region, 
the coiled-coil domain might play a supportive role in DNA binding.  
 
DNA binding models  
Several DNA recognition models have so far been proposed based on atomic models of separate 
subunits or subcomplexes of the MRN complex. All of them postulated that the DNA-binding 
interface is located on the catalytic core of the complex. A few possible locations of this 
interface have been under consideration. The DNA is recognized by the Mre11 nuclease domain 
and the binding could be further supported by Rad50 ATPase domains (Williams et al. 2009). 
Alternatively, both proteins could participate in forming one DNA-binding interface. This last 
hypothesis was proposed in a recent report showing tmRad50NBD-Mre11FL (Mre11 full-length) 
and tmRad50NBD-Mre11HLH structures (Lammens et al. 2011). The ATP-free “open” extended 
Mre11-Rad50 complex would recognize DNA ends via distantly located Rad50 monomers. 
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Subsequently, DNA-stimulated and ATP-dependent dimerization would result in closing of the 
whole complex on the DNA in such a way, that the catalytic domains of Rad50 and Mre11 
would form a clamp around the DNA duplex (Figure 36).  
 
 
 
Figure 36. Clamp model of DNA recognition by the Mre11-Rad50-Nbs1 complex. ATP binding 
induces dimerization of Rad50 monomers into a “closed” form where nuclease and ATPase domains of 
Mre11 and Rad50, respectively, would form a ring-shaped DNA-binding tunnel. Based on: (Lammens et 
al. 2011). 
 
More recent results, however, strongly argue against the “clamp” model. Structures of 
tmRad50NBD-Mre11FL in closed conformation from two prokaryotic species clearly show that in 
the fully dimerized MR assembly there is no channel wide enough to accommodate a DNA 
duplex (Lim et al. 2011; Mockel et al. 2012). These structures are contradictory not only to the 
“clamp” model but also to the DNA-bound pfMre11 structure published earlier (Williams et al. 
2008). In particular, the Rad50 dimer tightly associates with the Mre11 dimer and blocks the 
access to the Mre11 active site at the same position that was identified to form the DNA-binding 
pocket in the pfMre11-DNA model (Figure 7, Introduction). This outcome already showed that 
the mechanism of DNA binding might be much more complex as initially expected. Moreover, 
ATP binding and hydrolysis induces clear conformational changes in the Rad50 dimer that are 
transmitted to Mre11 and possibly to Nbs1 (Mockel et al. 2012). One could expect that DNA 
also induces conformational changes within the whole complex and perhaps together with ATP 
in a cooperative manner. This could mean that the DNA-binding interface is flexible rather that 
rigid and a number of distinct motifs on the MR assembly might govern the binding in an 
alternating manner. Furthermore, it was observed that the interface built up by the dimerizing 
Rad50 monomers located between the coiled-coil domains is positively charged and could serve 
as a DNA-binding platform (Figure 22, Introduction). This hypothesis was further complemented 
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with a postulation that the DNA duplex bound to MRN is partially unwound during ATP 
hydrolysis (Paull and Gellert 1999) and that one strand on the duplex could freely migrate 
through the Mre11/Rad50 clamp and be enzymatically processed by Mre11 (Mockel et al. 2012) 
(Figure 37).  
 
 
 
Figure 37. ATP-induced conformational change of the Mre11-Rad50 complex and its implication 
for DNA binding. In the ATP-bound (“closed”) form, Rad50 ATPase domains sterically seclude the 
Mre11 active site and impair postulated clamp formation around dsDNA. dsDNA could undergo partial 
unwinding and then be accessible to the Mre11 active site. Based on: (Mockel et al. 2012). 
 
Although the new tmRad50NBD-Mre11HLH-DNA structure does not clearly prove any of the 
previously postulated models of DNA binding, it also does not exclude some of these 
hypotheses. Firstly, the new structure definitely does not argue against the tempting idea of DNA 
passing along the positively charged groove located between the coiled-coils (Figure 22, 
Results). As visible in the arrangement of the molecules in the crystal lattice, this particular 
interface is occupied by a symmetry-related molecule of Rad50, which does not leave space for 
the DNA (Figure 38). Furthermore, several residues located on the groove were found to be 
crucial for DNA-binding activity in vitro and for telomere maintenance in vivo. Taken together, 
the putative binding groove is a strong candidate for a DNA-binding interface.  
The arrangement of the symmetry-related molecules in the crystal lattice is also most probably 
the reason why DNA binding is asymmetrical in the crystal. Crystal packing clearly shows that 
in each Rad50 dimer one coiled-coil domain supports DNA binding and the other is involved in 
crystal contacts to a neighbouring Rad50 molecule. Therefore, it is still be possible that in vivo 
the complex recognizes DNA in a symmetrical way.  
Discussion 
 
84 
 
 
 
Figure 38. Arrangement of the symmetry-related molecules in the crystal lattice. Left panel: cartoon 
representation, middle and right panels: surface representation. Red rings mark the putative the DNA-
binding groove (middle panel) and the DNA-free coiled-coil domain (right panel). Both positions are 
occupied by the symmetry-related molecule (shown in grey). 
 
Insights from in vitro functional studies 
In vitro studies showed that the structurally determined residues on Rad50 responsible for 
contacting DNA were indeed involved in DNA-binding activity of the protein. It could be also 
assumed that DNA-binding activity would depend on the DNA form, as in vivo the complex 
should recognize broken DNA ends. One could expect that nicked and most likely linearized 
plasmid would be bound by the protein more efficiently. Surprisingly, no difference in DNA 
binding-activity was observed for topologically different DNA forms. The tmRad50NBD-
Mre11HLH complex bound circular, linearized, supercoiled and relaxed DNA with comparable 
efficiency and did not show exhibit preference for binding to the exposed DNA ends. One 
explanation could be that the protein exhibits weak preference for certain forms of DNA in vitro 
and these could not be observed with the sensitivity of EMSA. Alternatively, it is be possible that 
the minimal subunit of the complex used in in vitro assays does not exhibit the full potential of 
the tmMR complex on DNA. It was shown before with the purified human MRN that the most 
efficient DNA binding is observed for the full-length complex containing all subunits (Paull and 
Gellert 1999). Following this notion, the situation in vivo might be even more complex, with 
other repair factors modulating DNA binding activity of the MRN (Limbo et al. 2007; Richard et 
al. 2011; Polo et al. 2012). Taken together, although no preference for binding certain DNA 
forms was observed in vitro, such divergent behaviour in vivo cannot be excluded. The 
Discussion 
 
85 
 
experimental setup employed for in vitro assays is very simplified and certainly does not reflect 
the complexity of the cellular system. At the same time, performed EMSAs could only provide 
qualitative and not quantitative information on the DNA-binding activity.  
Notably, the longer DNA used in DNA-binding tests, the better activity did the tmRad50NBD-
Mre11HLH exhibit. Significant difference was readily observed between 30 bp and 60 bp DNAs. 
This result suggests that that the DNA-binding interface is much more complex compared to 
what was determined by the atomic model of the tmRad50NBD-Mre11HLH-DNA and involves 
other motifs on the Mre11-Rad50 catalytic head. This hypothesis is further supported by the fact 
that the DNA used for crystallization is very short and does not reflect the high complexity if the 
chromatin structure – a physiological context in which the MRN complex has to recognize the 
damage site.  
 
Further mutational analyses in vitro showed that almost all point mutants of the tmRad50NBD-
Mre11HLH complex exhibited lower DNA-binding activity when compared to the wild-type 
protein. These residues are irregularly scattered on the surface of the globular Rad50 catalytic 
core and at first glance form a rather random interface (Figure 21, Results). It can be that already 
single substitutions change the surface potential of the whole construct so strongly that the DNA 
binding is affected even if a given residue does not participate in forming the DNA-binding 
interface. However, taking into consideration the position of the DNA in the crystal and that in 
vivo the DNA has to contact the nuclease domain of Mre11, it is possible that a number of 
residues on the globular Rad50 ATPase domain would mediate DNA binding. In vitro data 
where tmRad50NBD-Mre11HLH point mutants were tested for DNA-binding activity strongly 
support this notion. Conserved lysines R94 and K95 seem to have a special importance. These 
residues on both Rad50 monomers mark distant edges of the putative DNA-binding groove. 
Mutating these residues strongly impairs DNA binding and this effect is comparable with the 
K115E mutant identified as a direct protein-DNA contact in the structure. This result would on 
one hand support the notion that the positively charged groove extended between the coiled-coil 
domains of Rad50 is indeed responsible for DNA binding and on the other hand would point 
towards the idea, that a number of positively charged residues on the globular Rad50 catalytic 
head support this binding. It can be therefore postulated that the DNA binding through the 
positive patch or coordinated via the coiled-coil domain is guided along the side located centrally 
on the ATPase domains towards Mre11 active site (Figure 39). Also, one needs to consider that 
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the protein construct used for these studies represents only a small fraction of the full-length 
complex and therefore the details of the DNA binding cannot be extrapolated globally on the 
behaviour of the MRN in vivo. Taken together, mutational studies clearly show that the DNA-
binding interface is complex, dynamic and coordinated by many distinct motifs of the Mre11-
Rad50 catalytic head. 
 
 
Figure 39. Overlay of the tmRad50NBD-Mre11HLH-DNA (in colour) and fully dimerized tmRad50NBD-
Mre11FL structures (in grey; PDB entry: 3THO). DNA is located far from the Mre11 active sites. 
 
Insights from in vivo functional studies 
Conserved residues identified in the structure and in in vitro binding assays to play a role in the 
DNA-binding activity of the tmRad50NBD-Mre11HLH complex were also mutated in yeast S. 
cerevisiae. Further in vivo studies revealed the significance of these residues in DNA damage 
response, end joining and telomere maintenance. In the assays, the wild-type and knockout strain 
∆rad50 was compared  to the ∆rad50 strain rescued with wild-type and mutated Rad50 alleles. 
DNA damage response was dramatically impaired in mutants involved in ATP binding and 
hydrolysis (S1205R and E1235Q, respectively) to have a dramatic impact on cell survival on 
DNA-damaging agents. This was already reported together with the observation that inhibition 
of ATP binding has even more severe effect in DNA damage response (Moncalian et al. 2004; 
Bhaskara et al. 2007). An equally strong phenotype was also observed for the R1201E mutant. 
R1201 is one of the conserved residues of the putative binding groove on Rad50 dimer interface. 
This mutation showed already an effect in DNA binding activity in vitro. Its action in vivo is 
even more pronounced, with survival capability comparable to ∆rad50 strain. In the 
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tmRad50NBD-Mre11HLH structure R765 is relatively deeply buried in the groove and it is not clear 
if it could be directly involved in DNA binding unless the DNA molecule would be bent. At the 
same time R765 is located just a few aminoacids upstream from the signature motif and it is 
plausible that the mutation of this residue gives such a strong phenotype because of affecting the 
proper arrangement of the ATP binding cleft. However, the recombinant tmRad50NBD-Mre11HLH 
R765E mutant showed an insignificantly slower dimer formation upon AMPPNP addition and 
dimerized with the same efficiency as the wild-type protein. One possible explanation could be 
that in vivo the R1201E mutation (tmRad50 R765) strongly affects the surface charge of the 
groove, suggesting that this residue is crucial to the formation of the positively charged DNA-
binding interface. Alternatively, the R1201E mutation could have to no effect on ATP binding in 
vivo, but rather impair its hydrolysis, resulting in a phenotype almost identical to the E1235Q 
mutant. The R1201E mutation could also affect the proper arrangement of the Rad50 dimer 
rather than the dimer formation itself, which would in turn impair the MRX complex formation 
and/or function in vivo. One way to exclude the possibility of defects in the complex formation 
due to R1201E mutation would be to perform co-immunoprecipitation experiments and verify if 
all subunits of the complex are still present interacting.  
 
Other point mutations, including residues shown to be important for DNA binding in the 
structure and in in vitro assays did not affect S. cerevisiae survival on DNA-damaging agents. 
Changes in the phenotype were visible in the double-mutant K103E+R131E, combining residues 
responsible for most dramatic effect in EMSA. This effect can on one hand support in vitro data 
and on the other be in favour of the notion that the DNA binding is further mediated by a 
combination of the Rad50-Mre11motifs. 
 
Interestingly, some of the residues identified to be important for DNA binding in vitro but not 
exhibiting an altered phenotype in yeast response to DNA damage significantly affected telomere 
maintenance and end-joining activity. The two lysine residues K103 and K104 (R94 and K95 in 
tmRad50) marking the exits of the putative DNA-binding groove exhibited partially shorter 
telomeres and partially impaired end-joining repair. Interestingly, this effect was strongly 
enhanced in the K103E+R131E double mutant, but not in the K104E+R131E double mutant, and 
comparable to the Rad50 knock-out strain, although R131E single mutant showed normal 
telomere maintenance and end joining. Notably, the signature motif S1205R mutant was 
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deficient in all three analyzed in vivo processes: DNA-damage response, end-joining activity and 
telomere maintenance, whereas the Walker B E1235Q mutant exhibited defects in DNA-damage 
response and end joining but was fully proficient in telomere metabolism. Remarkably, the 
coiled-coil mutant N190D also showed separation-of-function, being proficient in DNA-damage 
response but defective in end joining. This result again points out that activities of the MRN 
complex are distinctly employed for different cellular processes and therefore it is possible that 
DNA binding mode depends on the process. 
 
An informative complement to the in vitro and in vivo studies would have been analyses of other 
MRN-dependent functions. This was attempted in ATM signalling experiment in X. laevis egg 
extract. Although it had been shown before that recombinant hMRN complex restores ATM 
signalling in xlMRN-immunodepleted extract (Costanzo et al. 2001), this result could never be 
reproduced in this work and for this reason structure-based mutations could not be checked for 
the importance in ATM signalling. Preparation of the responsive egg extract and the optimization 
of the immunodepletion and reaction conditions were successful. It was therefore assumed that 
the experiment failed either due to the substoichiometric Nbs1 concentration in the sample or 
low activity of the complex due to partial oligomerization or aggregation of the protein sample. 
This negative result was however surprising, since the procedure was carried out strictly 
according to previously published protocols.   
 
Summary and future perspectives 
In summary, presented structural and functional results give first insight into DNA binding by 
Rad50. The tmRad50NBD-Mre11HLH-DNA structure identified residues on the Rad50 catalytic 
head important to DNA binding. Additionally, involvement of the coiled-coil domain in 
supporting DNA binding was determined. Extensive mutational studies in vitro and in vivo not 
only supported these structural findings but also shed more light on other Rad50 motifs 
important to DNA recognition in different cellular processes.  
It became apparent that the DNA-binding interface is complex and involves a number of 
residues/motifs, likely to be located both on Rad50 and Mre11. Presumably, the DNA binding is 
dynamic and involved in a cross-talk between ATP binding and hydrolysis. DNA recognition 
and the binding mode can be also dependent on distinct cellular process accompanied by the 
MRN complex. As already emphasized, some particular residues in the scRad50 that did not turn 
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out to be crucial to the response to DNA damage had significant importance in telomere 
maintenance and end-joining repair. It would be interesting to look closely at the role of these 
residues in other cellular events employing the MRN complex such as meiosis and signalling. 
Different modes of DNA binding could be also supported by the MRN-associating factors that 
would modulate the binding mechanism and the activity of the complex, depending of the 
process.  
At the moment it is still difficult to fully understand which exactly structural features of the 
complex govern DNA recognition at the DSB site. In particular, it is not clear how the complex 
would sense a DNA end. More details would need to be obtained also to determine how exactly 
the coiled-coil domain contributes to DNA binding in different species since this segment of 
Rad50 is poorly conserved in sequence. It would be extremely insightful to have DNA-bound 
structures of larger subcomplexes of the MRN and be able to identify DNA-binding motifs on 
eukaryotic orthologues. Since the recent structures of fully dimerized prokaryotic Mre11-Rad50 
complexes argue against previously published pfMre11-DNA bound model, structure of a more 
complete catalytic head of the complex bound to DNA would help to determine the role of 
distinct subunits in forming the DNA-binding interface and address the hypothesis of the 
existence of two independent DNA-binding pockets: one located on Rad50 and the other on 
Mre11.  
Having all this information in hand, structure-guided functional studies would certainly 
contribute to dissecting individual MRN features responsible for the distinct roles in DNA repair, 
telomere maintenance, meiosis an many other cellular processes accompanied by MRN complex.  
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7. Abbreviations 
°C degree Celcius 
2-ME β-mercaptoethanol 
3D three-dimension 
6-FAM 6-carboxyfluorescein 
6His 6-histidine tag 
aa aminoacid 
Å angstrom 
AMPPNP adenosine 5´(ß,γ-imido)triphosphate 
A-T adenine-thymine pair 
ATLD ataxia-telangiectasia like disease 
ATM ataxia telangiectasia mutated 
ATP adenosine-5'-triphosphate 
BER base excision repair 
bp base pair (base pairs) 
BRCT breast cancer carboxy-terminus 
C-terminus carboxy-terminus 
CPT camptothecin 
CV colume volume 
Cy3-dCTP Cy3-labelled deoxycytidine triphosphate 
D. melanogaster Drosophila melanogaster 
DDR direct damage reversal 
DNA doexyribonucleic acid 
DNA-PK DNA-dependent protein kinase 
dNTP deoxyribonucleotide  
DSB double-strand break 
DSBR double-strand break repair 
dsDNA double-stranded DNA 
DTT dithiotreitol 
ECL enhanced chemoluminiscence  
E. coli Escherichia coli 
E. cuniculi Encephalitozoon cuniculi 
EDTA  ethylenediaminetetraacetic acid 
e. g.  exempli gratia (for example) 
EMSA electrophoretic mobility shift assay 
ESRF European Synchrotron Radiation Facility 
EtOH ethanol 
FHA forkhead associated 
FL full-length 
Fw forward 
G-C guanine-cytosine 
h hour (hours) 
Abbreviations 
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H. sapiens Homo sapiens 
HLH helix-loop-helix 
hMRN human MRN 
HPLC high performance liquid chromatography 
HPSF high purity salt free 
HR homologous recobination 
HU hydroxyurea 
i. e.  id est (that is) 
Ig immunoglobulin 
IPTG isopropyl-ß-D-thiogalactopyranosid 
IR ionizing radiation 
kDa kilo Dalton 
LB lysogeny broth 
M molar 
mA miliampere 
MDa mega dalton 
Mg magnesium 
min minute (minutes) 
MMEJ microhomology-mediated end joining 
MMS methyl methanesulfonate 
Mn manganese 
MR Mre11-Rad50 
MRN/MRX Mre11-Rad50-Nbs1 (Mre11-Rad50-Xrs2 in S. cerevisiae) 
N-terminus amino-terminus 
nt nucleotide 
NER nucleotide excision repair 
NBD nucleotide binding domain 
NBS Nijmegen breakage syndrome 
NBSLD Nijmegen breakage syndrome like disease 
NHEJ non homologous end joining 
Ni-NTA nickel-nitrilotriacetic acid 
No. number 
nt nucleotide 
OD600 optical density at 600nm 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PDB protein data bank 
PEG polyethylene glycol 
P. furiosus Pyrococcus furiosus 
pfRad50 Rad50 from P. furiosus 
pH potential of hydrogen 
PVDF polyvinylidene difluoride 
Abbreviations 
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R. m. s root mean square 
rcf relative centrifugal force 
ROS reactive oxygen species 
RPA replication protein A 
rpm rotation per min 
Rv reverse 
s second 
S. cerevisiae Saccharomyces cerevisiae 
S. frugiperda Spodoptera frugiperda 
S. pombe Schizosaccharomyces pombe 
scRad50 Rad50 from S. cerevisiae 
SDS sodium dodecyl-sulfate 
SLS Swiss Light Source 
SMC structural maintenance of chromosome 
ssDNA single-stranded DNA 
TA Tris-acetate 
TBST Tris buffered saline with Tween20 
TCA trichloroacetic acid 
Tcr T-cell receptor 
T. maritima Termothoga maritima 
tmMre11 Mre11 from T. maritima 
tmRad50 Rad50 from T. maritima 
T. ni Trichoplusia ni 
Tris tris(hydroxymethyl)aminomethane 
UV ultraviolet radiation 
V(D)J recombination variable-diverse-joining recombination 
WT wild-type 
X. laevis Xenopus laevis 
xlMre11 Mre11 from X. laevis 
xlMRN MRN from X. laevis 
YPD yeast extract peptone dextrose 
YT yeast extract tryptone 
Zn zinc 
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